{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T11:15:53Z","timestamp":1794222953649,"version":"4.8.0"},"reference-count":320,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["20230518"],"award-info":[{"award-number":["20230518"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU-A-025"],"award-info":[{"award-number":["CMU-A-025"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03589-3","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T15:33:41Z","timestamp":1752939221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Recent advances in engineered exosome-based therapies for ocular vascular disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Jian","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanhe","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binglun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingnan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"issue":"8","key":"3589_CR1","doi-asserted-by":"publisher","first-page":"e1255","DOI":"10.1111\/aos.14845","volume":"99","author":"F Plastino","year":"2021","unstructured":"Plastino F, Pesce NA, Andr\u00e9 H. MicroRNAs and the HIF\/VEGF axis in ocular neovascular diseases. Acta Ophthalmol. 2021;99(8):e1255\u201362.","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"3589_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/08820538.2022.2152706","volume":"38","author":"S Vishwakarma","year":"2023","unstructured":"Vishwakarma S, Kaur I. Molecular mediators and regulators of retinal angiogenesis. Semin Ophthalmol. 2023;38(2):124\u201333.","journal-title":"Semin Ophthalmol"},{"issue":"13","key":"3589_CR3","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.3390\/ijms21134758","volume":"21","author":"R Terao","year":"2020","unstructured":"Terao R, Kaneko H. Lipid signaling in ocular neovascularization. Int J Mol Sci. 2020;21(13):4758.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3589_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41433-021-01807-4","volume":"36","author":"G De Rossi","year":"2022","unstructured":"De Rossi G, Da Vitoria Lobo ME, Greenwood J, Moss SE. LRG1 as a novel therapeutic target in eye disease. Eye. 2022;36(2):328\u201340.","journal-title":"Eye"},{"issue":"4","key":"3589_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1124\/jpet.122.001563","volume":"386","author":"A Muniyandi","year":"2023","unstructured":"Muniyandi A, Hartman G, Song Y, Mijit M, Kelley M, Corson T. Beyond VEGF: targeting inflammation and other pathways for treatment of retinal disease. J Pharmacol Exp Ther. 2023;386(4):15\u201325.","journal-title":"J Pharmacol Exp Ther"},{"issue":"21","key":"3589_CR6","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.3390\/cells11213453","volume":"11","author":"H Heloter\u00e4","year":"2022","unstructured":"Heloter\u00e4 H, Kaarniranta K. A linkage between angiogenesis and inflammation in neovascular age-related macular degeneration. Cells. 2022;11(21):3453.","journal-title":"Cells"},{"issue":"3","key":"3589_CR7","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/ijms22031170","volume":"22","author":"A Pugazhendhi","year":"2021","unstructured":"Pugazhendhi A, Hubbell M, Jairam P, Ambati B. Neovascular macular degeneration: a review of etiology, risk factors, and recent advances in research and therapy. IJMS. 2021;22(3):1170.","journal-title":"IJMS"},{"key":"3589_CR8","doi-asserted-by":"publisher","first-page":"100921","DOI":"10.1016\/j.preteyeres.2020.100921","volume":"83","author":"PA Campochiaro","year":"2021","unstructured":"Campochiaro PA, Akhlaq A. Sustained suppression of VEGF for treatment of retinal\/choroidal vascu lar diseases. Progr Retinal Eye Res. 2021;83:100921.","journal-title":"Progr Retinal Eye Res"},{"key":"3589_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005139.pub3","author":"S Solomon","year":"2014","unstructured":"Solomon S, Lindsley K, Vedula S, Krzystolik M, Hawkins B. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Datab Syst Rev. 2014. https:\/\/doi.org\/10.1002\/14651858.CD005139.pub3.","journal-title":"Cochrane Datab Syst Rev"},{"key":"3589_CR10","doi-asserted-by":"publisher","first-page":"104924","DOI":"10.1016\/j.phrs.2020.104924","volume":"159","author":"H-Y Li","year":"2020","unstructured":"Li H-Y, Yuan Y, Fu Y-H, Wang Y, Gao X-Y. Hypoxia-inducible factor-1\u03b1: a promising therapeutic target for vascul opathy in diabetic retinopathy. Pharmacol Res. 2020;159:104924.","journal-title":"Pharmacol Res"},{"key":"3589_CR11","doi-asserted-by":"publisher","first-page":"1411278","DOI":"10.3389\/fmed.2024.1411278","volume":"11","author":"S Cheng","year":"2024","unstructured":"Cheng S, Zhang S, Huang M, Liu Y, Zou X, Chen X, Zhang Z. Treatment of neovascular age-related macular degeneration with anti-vascular endothelial growth factor drugs: progress from mechanisms to clinical applications. Front Med. 2024;11:1411278.","journal-title":"Front Med"},{"issue":"7","key":"3589_CR12","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.3390\/ijms22073427","volume":"22","author":"H Noma","year":"2021","unstructured":"Noma H, Yasuda K, Shimura M. Involvement of cytokines in the pathogenesis of diabetic macular edema. IJMS. 2021;22(7):3427.","journal-title":"IJMS"},{"issue":"1","key":"3589_CR13","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1080\/07853890.2022.2064541","volume":"54","author":"A Arrigo","year":"2022","unstructured":"Arrigo A, Aragona E, Bandello F. VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy. Ann Med. 2022;54(1):1089\u2013111.","journal-title":"Ann Med"},{"issue":"2","key":"3589_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/medicina61020260","volume":"61","author":"M Brinkmann","year":"2025","unstructured":"Brinkmann M, Muller T, Koster M, Schweighofer J, Danckwardt M, Giannaccare G, Marolo P, Borrelli E, Reibaldi M, El-Shabrawi Y, Toro MD. Optical coherence tomography angiography flow signal in non-treatment-naive patients with neovascular age-related macular degeneration treated with faricimab. Medicina (Kaunas). 2025;61(2):260.","journal-title":"Medicina (Kaunas)"},{"key":"3589_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2024.100742","volume":"100","author":"HM Kim","year":"2024","unstructured":"Kim HM, Woo SJ. Immunogenicity and potential for intraocular inflammation of intravitreal anti-VEGF drugs. Curr Ther Res Clin Exp. 2024;100: 100742.","journal-title":"Curr Ther Res Clin Exp"},{"key":"3589_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-025-03732-2","author":"A Sharma","year":"2025","unstructured":"Sharma A, Woo SJ, Lee CS, Kumar N, Parachuri N, Bandello F, Loewenstein A, Kuppermann BD. Aflibercept 2 mg biosimilars-will they lead the Anti-VEGF biosimilar world globally. Eye (Lond). 2025. https:\/\/doi.org\/10.1038\/s41433-025-03732-2.","journal-title":"Eye (Lond)"},{"issue":"1","key":"3589_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12967-023-03937-7","volume":"21","author":"LM Khachigian","year":"2023","unstructured":"Khachigian LM, Liew G, Teo KYC, Wong TY, Mitchell P. Emerging therapeutic strategies for unmet need in neovascular age-rela ted macular degeneration. J Transl Med. 2023;21(1):133.","journal-title":"J Transl Med"},{"issue":"11","key":"3589_CR18","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3390\/biom12111629","volume":"12","author":"RH ElSheikh","year":"2022","unstructured":"ElSheikh RH, Chauhan MZ, Sallam AB. Current and novel therapeutic approaches for treatment of neovascular age-related macular degeneration. Biomolecules. 2022;12(11):1629.","journal-title":"Biomolecules"},{"issue":"17","key":"3589_CR19","doi-asserted-by":"publisher","first-page":"2304626","DOI":"10.1002\/adhm.202304626","volume":"13","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Xu M, Shen W, Xu Y, Shao A, Xu P, Yao K, Han H, Ye J. Recent advances in nanomedicine for ocular fundus neovascularization disease management. Adv Healthcare Mater. 2024;13(17):2304626.","journal-title":"Adv Healthcare Mater"},{"key":"3589_CR20","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2147\/OPTH.S207978","volume":"14","author":"M Schargus","year":"2020","unstructured":"Schargus M, Frings A. Issues with intravitreal administration of anti-VEGF drugs. Clin Ophthalmol (Auckland, NZ). 2020;14:897\u2013904.","journal-title":"Clin Ophthalmol (Auckland, NZ)."},{"issue":"21","key":"3589_CR21","doi-asserted-by":"publisher","first-page":"8242","DOI":"10.3390\/ijms21218242","volume":"21","author":"F Ricci","year":"2020","unstructured":"Ricci F, Bandello F, Navarra P, Staurenghi G, Stumpp M, Zarbin M. Neovascular age-related macular degeneration: therapeutic management a nd new-upcoming approaches. IJMS. 2020;21(21):8242.","journal-title":"IJMS"},{"issue":"16","key":"3589_CR22","doi-asserted-by":"publisher","first-page":"13004","DOI":"10.3390\/ijms241613004","volume":"24","author":"B-H Moon","year":"2023","unstructured":"Moon B-H, Kim Y, Kim S-Y. Twenty years of anti-vascular endothelial growth factor therapeutics in neovascular age-related macular degeneration treatment. IJMS. 2023;24(16):13004.","journal-title":"IJMS"},{"key":"3589_CR23","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.7150\/thno.98467","volume":"14","author":"P Zhou","year":"2024","unstructured":"Zhou P, Zhang S, Li L, Zhang R, Guo G, Zhang Y, Wang R, Liu M, Wang Z, Zhao H, Yang G, Xie S, Ran J. Targeted degradation of VEGF with bispecific aptamer-based LYTACs ameliorates pathological retinal angiogenesis. Theranostics. 2024;14:4983\u20135000.","journal-title":"Theranostics"},{"issue":"3","key":"3589_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/ICU.0000000000000850","volume":"33","author":"D Patel","year":"2022","unstructured":"Patel D, Patel SN, Chaudhary V, Garg SJ. Complications of intravitreal injections: 2022. Curr Opin Ophthalmol. 2022;33(3):137\u201346.","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"3589_CR25","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/jcm10050981","volume":"10","author":"JT Cox","year":"2021","unstructured":"Cox JT, Eliott D, Sobrin L. Inflammatory complications of intravitreal anti-VEGF injections. JCM. 2021;10(5):981.","journal-title":"JCM"},{"key":"3589_CR26","doi-asserted-by":"publisher","first-page":"100862","DOI":"10.1016\/j.preteyeres.2020.100862","volume":"80","author":"GB Melo","year":"2021","unstructured":"Melo GB, da Cruz NF, Emerson GG, Rezende FA, Meyer CH, Uchiyama S, Carpenter J, Shiroma HF, Farah ME, Maia M, Rodrigues EB. Critical analysis of techniques and materials used in devices, syringe s, and needles used for intravitreal injections. Prog Retinal Eye Res. 2021;80:100862.","journal-title":"Prog Retinal Eye Res."},{"issue":"6","key":"3589_CR27","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1001\/jamaophthalmol.2021.0640","volume":"139","author":"N Ngo Ntjam","year":"2021","unstructured":"Ngo Ntjam N, Thulliez M, Paintaud G, Salvo F, Angoulvant D, Pisella P-J, Bejan-Angoulvant T. Cardiovascular adverse events with intravitreal anti-vascular endothelial growth factor drugs. JAMA Ophthalmol. 2021;139(6):610\u20139.","journal-title":"JAMA Ophthalmol."},{"issue":"12","key":"3589_CR28","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.ophtha.2022.07.009","volume":"129","author":"NA Patel","year":"2022","unstructured":"Patel NA, Acaba-Berrocal LA, Hoyek S, Fan KC, Martinez-Castellanos MA, Baumal CR, Harper CA, Berrocal AM, Wei-Chi W, Spencer R, Kusaka S, Quiram P, Asilis J, Blair MP, Agarwal S, Ells A, Besirli CG, Tsui I, Lee TC, Nagiel A, Kychenthal A, Kovarik J, Orlin A, Alexander J, Dedania VS, Ozdek S, Shami MJ, Regan C, Desai S, Levin MR, Chong DY, Gupta M, Pflugrath A, Abbey A, Fuller CG, Coors LE, Yannuzzi N, Negron C, Al-khersan H, Runge P, Ozdemir HB, Kucukbalci T, Iwahashi C, Solinski M, Sutter D, Sears J, Sonnie C, Portney D, Duker J, Lenis T, Di-Luciano A, Chamartin P, Kothari N, Ortiz-Ramirez GY, Amadeo Oreggioni GP, Naravane AV, Belin PJ, Vicioso NL, Vavvas D, Hartnett ME, Chan RVP, Nudleman E, Moshfeghi DM, Amphornphruet A, Chiang M, Shapiro MJ. Practice patterns and outcomes of intravitreal anti-VEGF injection for retinopathy of prematurity. Ophthalmology. 2022;129(12):1380\u20138.","journal-title":"Ophthalmology"},{"issue":"5","key":"3589_CR29","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/ICU.0000000000000783","volume":"32","author":"JM Barnett","year":"2021","unstructured":"Barnett JM, Hubbard GB. Complications of retinopathy of prematurity treatment. Curr Opin Ophthalmol. 2021;32(5):475\u201381.","journal-title":"Curr Opin Ophthalmol"},{"key":"3589_CR30","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S383101","author":"M Xu","year":"2023","unstructured":"Xu M, Fan R, Fan X, Shao Y, Li X. Progress and Challenges of Anti-VEGF Agents and Their Sustained-Releas e Strategies for Retinal Angiogenesis. Drug Des Dev Ther. 2023. https:\/\/doi.org\/10.2147\/DDDT.S383101.","journal-title":"Drug Des Dev Ther"},{"issue":"1","key":"3589_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14728222.2022.2030706","volume":"26","author":"AT Wolf","year":"2022","unstructured":"Wolf AT, Harris A, Oddone F, Siesky B, Verticchio Vercellin A, Ciulla TA. Disease progression pathways of wet AMD: opportunities for new target discovery. Exp Opin Therap Targets. 2022;26(1):5\u201312.","journal-title":"Exp Opin Therap Targets."},{"issue":"5","key":"3589_CR32","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3390\/cells10051049","volume":"10","author":"JO Wallsh","year":"2021","unstructured":"Wallsh JO, Gallemore RP. Anti-VEGF-resistant retinal diseases: a review of the latest treatment options. Cells. 2021;10(5):1049.","journal-title":"Cells"},{"key":"3589_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.addr.2018.03.013","volume":"126","author":"CML Lau","year":"2018","unstructured":"Lau CML, Yu Y, Jahanmir G, Chau Y. Controlled release technology for anti-angiogenesis treatment of posterior eye diseases: current status and challenges. Adv Drug Deliv Rev. 2018;126:145\u201361.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"3589_CR34","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12951-024-02614-1","volume":"22","author":"X Liu","year":"2024","unstructured":"Liu X, Huang K, Zhang F, Huang G, Wang L, Wu G, Ren H, Yang G, Lin Z. Multifunctional nano-in-micro delivery systems for targeted therapy in fundus neovascularization diseases. J Nanobiotechnology. 2024;22(1):354.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"3589_CR35","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12974-024-03155-y","volume":"21","author":"B Ni","year":"2024","unstructured":"Ni B, Yang Z, Zhou T, Zhou H, Zhou Y, Lin S, Xu H, Lin X, Yi W, He C, Liu X. Therapeutic intervention in neuroinflammation for neovascular ocular diseases through targeting the cGAS-STING-necroptosis pathway. J Neuroinflammation. 2024;21(1):164.","journal-title":"J Neuroinflammation"},{"key":"3589_CR36","doi-asserted-by":"publisher","first-page":"103200","DOI":"10.1016\/j.cis.2024.103200","volume":"329","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Watson S, Ramaswamy Y, Singh G. Intravitreal therapeutic nanoparticles for age-related macular degeneration: design principles, progress and opportunities. Adv Colloid Interface Sci. 2024;329:103200.","journal-title":"Adv Colloid Interface Sci"},{"issue":"8","key":"3589_CR37","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1080\/17425247.2021.1888925","volume":"18","author":"P Sharma","year":"2021","unstructured":"Sharma P, Mittal S. Nanotechnology: revolutionizing the delivery of drugs to treat age-related macular degeneration. Expert Opin Drug Deliv. 2021;18(8):1131\u201349.","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"3589_CR38","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1021\/acs.molpharmaceut.0c00224","volume":"18","author":"Q Li","year":"2020","unstructured":"Li Q, Weng J, Wong SN, Thomas Lee WY, Chow SF. Nanoparticulate drug delivery to the retina. Mol Pharm. 2020;18(2):506\u201321.","journal-title":"Mol Pharm"},{"key":"3589_CR39","doi-asserted-by":"publisher","first-page":"938348","DOI":"10.3389\/fmolb.2022.938348","volume":"9","author":"M Zhang","year":"2022","unstructured":"Zhang M, Lu N, Li Q, Cui M, Zhang M. Editorial: drug delivery system based on nanoparticles for inflammation and cancer therapy. Front Mol Biosci. 2022;9:938348.","journal-title":"Front Mol Biosci"},{"key":"3589_CR40","doi-asserted-by":"publisher","first-page":"1254356","DOI":"10.3389\/fbioe.2023.1254356","volume":"11","author":"H Chen","year":"2023","unstructured":"Chen H, Yao H, Chi J, Li C, Liu Y, Yang J, Yu J, Wang J, Ruan Y, Pi J, Xu J-F. Engineered exosomes as drug and RNA co-delivery system: new hope for enhanced therapeutics. Front Bioeng Biotechnol. 2023;11:1254356.","journal-title":"Front Bioeng Biotechnol"},{"issue":"12","key":"3589_CR41","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3390\/pharmaceutics12121171","volume":"12","author":"NL Klyachko","year":"2020","unstructured":"Klyachko NL, Arzt CJ, Li SM, Gololobova OA, Batrakova EV. Extracellular vesicle-based therapeutics: preclinical and clinical investigations. Pharmaceutics. 2020;12(12):1171.","journal-title":"Pharmaceutics"},{"key":"3589_CR42","doi-asserted-by":"publisher","first-page":"113835","DOI":"10.1016\/j.addr.2021.113835","volume":"176","author":"W Ke","year":"2021","unstructured":"Ke W, Afonin KA. Exosomes as natural delivery carriers for programmable therapeutic nuc leic acid nanoparticles (NANPs). Adv Drug Deliv Rev. 2021;176:113835.","journal-title":"Adv Drug Deliv Rev"},{"key":"3589_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2018.12.045","volume":"86","author":"W Liao","year":"2019","unstructured":"Liao W, Du Y, Zhang C, Pan F, Yao Y, Zhang T, Peng Q. Exosomes: the next generation of endogenous nanomaterials for advanced drug delivery and therapy. Acta Biomater. 2019;86:1\u201314.","journal-title":"Acta Biomater"},{"key":"3589_CR44","doi-asserted-by":"publisher","first-page":"113910","DOI":"10.1016\/j.addr.2021.113910","volume":"179","author":"P Fu","year":"2021","unstructured":"Fu P, Zhang J, Li H, Mak M, Xu W, Tao Z. Extracellular vesicles as delivery systems at nano-\/micro-scale. Adv Drug Deliv Rev. 2021;179:113910.","journal-title":"Adv Drug Deliv Rev"},{"key":"3589_CR45","doi-asserted-by":"publisher","first-page":"103628","DOI":"10.1016\/j.critrevonc.2022.103628","volume":"172","author":"D Ferreira","year":"2022","unstructured":"Ferreira D, Moreira JN, Rodrigues LR. New advances in exosome-based targeted drug delivery systems. Crit Rev Oncol Hematol. 2022;172:103628.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3589_CR46","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","volume":"11","author":"Y Liang","year":"2021","unstructured":"Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11:3183\u201395.","journal-title":"Theranostics"},{"key":"3589_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-025-03710-8","author":"CMG Cheung","year":"2025","unstructured":"Cheung CMG. Age-related macular degeneration in 2025- opportunities and challenges. Eye (Lond). 2025. https:\/\/doi.org\/10.1038\/s41433-025-03710-8.","journal-title":"Eye (Lond)"},{"issue":"8","key":"3589_CR48","doi-asserted-by":"publisher","first-page":"7728","DOI":"10.1021\/acsnano.4c12327","volume":"19","author":"S Wang","year":"2025","unstructured":"Wang S, Chen X, Liu Y, Jiang Y, Li J, Ren L, Wang J, Wang Z, Li Y, Wu H, Zhang Y, Gao Y, Wang L. Hybrid biomembrane-functionalized nanorobots penetrate the vitreous body of the eye for the treatment of retinal vein occlusion. ACS Nano. 2025;19(8):7728\u201341.","journal-title":"ACS Nano"},{"key":"3589_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2023.109680","volume":"237","author":"W Nan","year":"2023","unstructured":"Nan W, He Y, Shen S, Wu M, Wang S, Zhang Y. BMP4 inhibits corneal neovascularization by interfering with tip cells in angiogenesis. Exp Eye Res. 2023;237: 109680.","journal-title":"Exp Eye Res"},{"issue":"3","key":"3589_CR50","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/cells12030494","volume":"12","author":"MV Vaglienti","year":"2023","unstructured":"Vaglienti MV, Subirada PV, Joray MB, Bonacci G, Sanchez MC. Protective effect of NO(2)-OA on oxidative stress, gliosis, and pro-angiogenic response in muller glial cells. Cells. 2023;12(3):494.","journal-title":"Cells"},{"issue":"1","key":"3589_CR51","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/jcmm.13348","volume":"22","author":"F Pisani","year":"2018","unstructured":"Pisani F, Cammalleri M, Dal Monte M, Locri F, Mola MG, Nicchia GP, Frigeri A, Bagnoli P, Svelto M. Potential role of the methylation of VEGF gene promoter in response to hypoxia in oxygen-induced retinopathy: beneficial effect of the absence of AQP4. J Cell Mol Med. 2018;22(1):613\u201327.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"3589_CR52","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3892\/mmr.2021.11883","volume":"23","author":"B Wang","year":"2021","unstructured":"Wang B, Zhang C, Chu D, Ma X, Yu T, Liu X, Hu C. Astragaloside IV improves angiogenesis under hypoxic conditions by enhancing hypoxia-inducible factor-1alpha SUMOylation. Mol Med Rep. 2021;23(4):244.","journal-title":"Mol Med Rep"},{"issue":"7","key":"3589_CR53","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1161\/ATVBAHA.118.312190","volume":"39","author":"Z Ali","year":"2019","unstructured":"Ali Z, Mukwaya A, Biesemeier A, Ntzouni M, Ramskold D, Giatrellis S, Mammadzada P, Cao R, Lennikov A, Marass M, Gerri C, Hildesjo C, Taylor M, Deng Q, Peebo B, Del Peso L, Kvanta A, Sandberg R, Schraermeyer U, Andre H, Steffensen JF, Lagali N, Cao Y, Kele J, Jensen LD. Intussusceptive vascular remodeling precedes pathological neovascularization. Arterioscler Thromb Vasc Biol. 2019;39(7):1402\u201318.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3589_CR54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cytogfr.2017.11.005","volume":"39","author":"J Mesquita","year":"2018","unstructured":"Mesquita J, Castro-de-Sousa JP, Vaz-Pereira S, Neves A, Passarinha LA, Tomaz CT. Vascular endothelial growth factors and placenta growth factor in retinal vasculopathies: current research and future perspectives. Cytokine Growth Factor Rev. 2018;39:102\u201315.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10","key":"3589_CR55","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41419-020-03076-7","volume":"11","author":"A Sui","year":"2020","unstructured":"Sui A, Chen X, Shen J, Demetriades AM, Yao Y, Yao Y, Zhu Y, Shen X, Xie B. Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1beta\/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model. Cell Death Dis. 2020;11(10):901.","journal-title":"Cell Death Dis"},{"key":"3589_CR56","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","volume":"49","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro PA. Molecular pathogenesis of retinal and choroidal vascular diseases. Prog Retin Eye Res. 2015;49:67\u201381.","journal-title":"Prog Retin Eye Res"},{"key":"3589_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119935","volume":"243","author":"SF Hackett","year":"2020","unstructured":"Hackett SF, Fu J, Kim YC, Tsujinaka H, Shen J, Lima ESR, Khan M, Hafiz Z, Wang T, Shin M, Anders NM, He P, Ensign LM, Hanes J, Campochiaro PA. Sustained delivery of acriflavine from the suprachoroidal space provides long term suppression of choroidal neovascularization. Biomaterials. 2020;243: 119935.","journal-title":"Biomaterials"},{"issue":"10","key":"3589_CR58","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s00417-009-1133-3","volume":"247","author":"CM Sheridan","year":"2009","unstructured":"Sheridan CM, Pate S, Hiscott P, Wong D, Pattwell DM, Kent D. Expression of hypoxia-inducible factor-1alpha and -2alpha in human choroidal neovascular membranes. Graefes Arch Clin Exp Ophthalmol. 2009;247(10):1361\u20137.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3589_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2024.110111","volume":"248","author":"WH Almalki","year":"2024","unstructured":"Almalki WH, Almujri SS. The impact of NF-kappaB on inflammatory and angiogenic processes in age-related macular degeneration. Exp Eye Res. 2024;248: 110111.","journal-title":"Exp Eye Res"},{"key":"3589_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2024.12.004","author":"A Servillo","year":"2024","unstructured":"Servillo A, Scandale P, Oldoni G, Begar PG, Bandello F, Miserocchi E, Cicinelli MV. Inflammatory choroidal neovascularization: an evidence-based update. Surv Ophthalmol. 2024. https:\/\/doi.org\/10.1016\/j.survophthal.2024.12.004.","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"3589_CR61","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.18240\/ijo.2022.11.02","volume":"15","author":"QY Gong","year":"2022","unstructured":"Gong QY, Hu GY, Yu SQ, Qian TW, Xu X. Comprehensive assessment of growth factors, inflammatory mediators, and cytokines in vitreous from patients with proliferative diabetic retinopathy. Int J Ophthalmol. 2022;15(11):1736\u201342.","journal-title":"Int J Ophthalmol"},{"issue":"6","key":"3589_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166708","volume":"1869","author":"Y Bai","year":"2023","unstructured":"Bai Y, Jiao X, Hu J, Xue W, Zhou Z, Wang W. WTAP promotes macrophage recruitment and increases VEGF secretion via N6-methyladenosine modification in corneal neovascularization. Biochim Biophys Acta Mol Basis Dis. 2023;1869(6): 166708.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"10","key":"3589_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30840","volume":"10","author":"Y Tu","year":"2024","unstructured":"Tu Y, Luo Y, Zhao Q, Zeng Y, Leng K, Zhu M. Role of macrophage in ocular neovascularization. Heliyon. 2024;10(10): e30840.","journal-title":"Heliyon"},{"issue":"1","key":"3589_CR64","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13578-022-00927-y","volume":"12","author":"C Cai","year":"2022","unstructured":"Cai C, Meng C, He S, Gu C, Lhamo T, Draga D, Luo D, Qiu Q. DNA methylation in diabetic retinopathy: pathogenetic role and potential therapeutic targets. Cell Biosci. 2022;12(1):186.","journal-title":"Cell Biosci"},{"issue":"1","key":"3589_CR65","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41420-024-02076-2","volume":"10","author":"B Bhargavan","year":"2024","unstructured":"Bhargavan B, Chhunchha B, Kubo E, Singh DP. DNA methylation as an epigenetic mechanism in the regulation of LEDGF expression and biological response in aging and oxidative stress. Cell Death Discov. 2024;10(1):296.","journal-title":"Cell Death Discov"},{"issue":"1","key":"3589_CR66","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1167\/iovs.65.1.14","volume":"65","author":"S Li","year":"2024","unstructured":"Li S, Sun D, Chen S, Zhang S, Gu Q, Shen Y, Xu L, Xu X, Wei F, Wang N. UCP2-SIRT3 signaling relieved hyperglycemia-induced oxidative stress and senescence in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2024;65(1):14.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"3589_CR67","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/s41401-024-01262-3","volume":"45","author":"SQ Huang","year":"2024","unstructured":"Huang SQ, Cao KX, Wang CL, Chen PL, Chen YX, Zhang YT, Yu SH, Bai ZX, Guo S, Liao MX, Li QW, Zhang GQ, He J, Xu YM. Decreasing mitochondrial fission ameliorates HIF-1alpha-dependent pathological retinal angiogenesis. Acta Pharmacol Sin. 2024;45(7):1438\u201350.","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"3589_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2023.119573","volume":"1871","author":"D Averill-Bates","year":"2024","unstructured":"Averill-Bates D. Reactive oxygen species and cell signaling. Review. Biochim Biophys Acta Mol Cell Res. 2024;1871(2): 119573.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3589_CR69","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jconrel.2024.11.011","volume":"377","author":"X Jiang","year":"2025","unstructured":"Jiang X, Liu C, Zhang Q, Lv Y, Lu C, Su W, Zhou J, Zhang H, Gong H, Liu Y, Yuan S, Chen Y, Qu D. Strategic delivery of rapamycin and ranibizumab with intravitreal hydrogel depot disrupts multipathway-driven angiogenesis loop for boosted wAMD therapy. J Control Release. 2025;377:239\u201355.","journal-title":"J Control Release"},{"issue":"1","key":"3589_CR70","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s11658-021-00283-8","volume":"26","author":"M Zhao","year":"2021","unstructured":"Zhao M, Wang S, Zuo A, Zhang J, Wen W, Jiang W, Chen H, Liang D, Sun J, Wang M. HIF-1\u03b1\/JMJD1A signaling regulates inflammation and oxidative stress following hyperglycemia and hypoxia-induced vascular cell injury. Cell Mol Biol Lett. 2021;26(1):40.","journal-title":"Cell Mol Biol Lett"},{"issue":"4","key":"3589_CR71","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.sjopt.2018.05.002","volume":"32","author":"AS Al-Kharashi","year":"2018","unstructured":"Al-Kharashi AS. Role of oxidative stress, inflammation, hypoxia and angiogenesis in the development of diabetic retinopathy. Saudi J Ophthalmol. 2018;32(4):318\u201323.","journal-title":"Saudi J Ophthalmol"},{"issue":"21","key":"3589_CR72","doi-asserted-by":"publisher","first-page":"11850","DOI":"10.3390\/ijms252111850","volume":"25","author":"JV Srejovic","year":"2024","unstructured":"Srejovic JV, Muric MD, Jakovljevic VL, Srejovic IM, Sreckovic SB, Petrovic NT, Todorovic DZ, Bolevich SB, Sarenac Vulovic TS. Molecular and cellular mechanisms involved in the pathophysiology of retinal vascular disease-interplay between inflammation and oxidative stress. Int J Mol Sci. 2024;25(21):11850.","journal-title":"Int J Mol Sci"},{"key":"3589_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123433","volume":"364","author":"X Wang","year":"2025","unstructured":"Wang X, Gong L, Wei C, Zhao Y, Ran L, Li P, Gu W, Wu X, Liang Z, Wang X. Inhibition of NSUN6 protects against intermittent hypoxia-induced oxidative stress and inflammatory response in adipose tissue through suppressing macrophage ferroptosis and M1 polarization. Life Sci. 2025;364: 123433.","journal-title":"Life Sci"},{"issue":"8","key":"3589_CR74","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.3390\/ijms26083463","volume":"26","author":"ME Ochoa Hern\u00e1ndez","year":"2025","unstructured":"Ochoa Hern\u00e1ndez ME, Lewis-Luj\u00e1n LM, Burboa Zazueta MG, Del Castillo Castro T, De La Re Vega E, G\u00e1lvez-Ruiz JC, Trujillo-L\u00f3pez S, L\u00f3pez Torres MA, Iloki-Assanga SB. Role of oxidative stress and inflammation in age related macular degeneration: insights into the retinal pigment epithelium (RPE). Int J Mol Sci. 2025;26(8):3463.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3589_CR75","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1007\/s10571-023-01383-z","volume":"43","author":"SM Zhang","year":"2023","unstructured":"Zhang SM, Fan B, Li YL, Zuo ZY, Li GY. Oxidative stress-involved mitophagy of retinal pigment epithelium and retinal degenerative diseases. Cell Mol Neurobiol. 2023;43(7):3265\u201376.","journal-title":"Cell Mol Neurobiol"},{"key":"3589_CR76","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.omtm.2021.06.007","volume":"22","author":"W Su","year":"2021","unstructured":"Su W, Sun S, Tian B, Tai PWL, Luo Y, Ko J, Zhan W, Ke X, Zheng Q, Li X, Yan H, Gao G, Lin H. Efficacious, safe, and stable inhibition of corneal neovascularization by AAV-vectored anti-VEGF therapeutics. Mol Ther Methods Clin Dev. 2021;22:107\u201321.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"3589_CR77","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.trsl.2018.12.006","volume":"207","author":"X Li","year":"2019","unstructured":"Li X, Liu J, Hoh J, Liu J. Muller cells in pathological retinal angiogenesis. Transl Res. 2019;207:96\u2013106.","journal-title":"Transl Res"},{"key":"3589_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2025.110243","volume":"251","author":"K Otsuka","year":"2025","unstructured":"Otsuka K, Morita A, Kashihara T, Nakahara T. Pharmacological depletion of pericytes induces diabetic retinopathy-like abnormal blood vessels in neonatal rat retina. Exp Eye Res. 2025;251: 110243.","journal-title":"Exp Eye Res"},{"issue":"6","key":"3589_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7555\/JBR.37.20230314","volume":"38","author":"LJ Shi","year":"2024","unstructured":"Shi LJ, Ge H, Ye F, Li X, Jiang Q. The role of pericyte in ocular vascular diseases. J Biomed Res. 2024;38(6):1\u201310.","journal-title":"J Biomed Res"},{"issue":"10","key":"3589_CR80","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202302624R","volume":"38","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Yan X, Han H, Wang Y, Sun J. Pericyte in retinal vascular diseases: a multifunctional regulator and potential therapeutic target. FASEB J. 2024;38(10): e23679.","journal-title":"FASEB J"},{"issue":"3","key":"3589_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2023.110615","volume":"115","author":"JS Ren","year":"2023","unstructured":"Ren JS, Bai W, Ding JJ, Zhao Y, Wang SY, Chen X, Jiang Q. The role of PIWIL4 and piRNAs in the development of choroidal neovascularization. Genomics. 2023;115(3): 110615.","journal-title":"Genomics"},{"issue":"13","key":"3589_CR82","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1167\/iovs.65.13.30","volume":"65","author":"M Liukkonen","year":"2024","unstructured":"Liukkonen M, Helotera H, Siintamo L, Ghimire B, Mattila P, Kivinen N, Kostanek J, Watala C, Hytti M, Hyttinen J, Koskela A, Blasiak J, Kaarniranta K. Oxidative stress and inflammation-related mRNAs are elevated in serum of a Finnish wet AMD cohort. Invest Ophthalmol Vis Sci. 2024;65(13):30.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"3589_CR83","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/antiox11020248","volume":"11","author":"BB Vidovi\u0107","year":"2022","unstructured":"Vidovi\u0107 BB, Milin\u010di\u0107 DD, Mar\u010deti\u0107 MD, Djuri\u0161 JD, Ili\u0107 TD, Kosti\u0107 A, Pe\u0161i\u0107 MB. Health benefits and applications of goji berries in functional food products development: a review. Antioxidants (Basel). 2022;11(2):248.","journal-title":"Antioxidants (Basel)"},{"key":"3589_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100954","volume":"84","author":"A Uemura","year":"2021","unstructured":"Uemura A, Fruttiger M, D\u2019Amore PA, De Falco S, Joussen AM, Sennlaub F, Brunck LR, Johnson KT, Lambrou GN, Rittenhouse KD, Langmann T. VEGFR1 signaling in retinal angiogenesis and microinflammation. Prog Retin Eye Res. 2021;84: 100954.","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"3589_CR85","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3390\/ph16070939","volume":"16","author":"A Yazdanyar","year":"2023","unstructured":"Yazdanyar A, Cai CL, Aranda JV, Shrier E, Beharry KD. Comparison of bevacizumab and aflibercept for suppression of angiogenesis in human retinal microvascular endothelial cells. Pharmaceuticals (Basel). 2023;16(7):939.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"3589_CR86","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","volume":"29","author":"SA Patel","year":"2023","unstructured":"Patel SA, Nilsson MB, Le X, Cascone T, Jain RK, Heymach JV. Molecular mechanisms and future implications of VEGF\/VEGFR in cancer therapy. Clin Cancer Res. 2023;29(1):30\u20139.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3589_CR87","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41433-020-01377-x","volume":"35","author":"AM Joussen","year":"2021","unstructured":"Joussen AM, Ricci F, Paris LP, Korn C, Quezada-Ruiz C, Zarbin M. Angiopoietin\/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data. Eye. 2021;35(5):1305\u201316.","journal-title":"Eye"},{"key":"3589_CR88","first-page":"22","volume":"22","author":"M Colucciello","year":"2025","unstructured":"Colucciello M, Khanani AM, Fasrs JIL, Farvo F. Controversies in care: the evidence that Ang-2 suppression confers a clinical benefit. Retinal Phys. 2025;22:22.","journal-title":"Retinal Phys."},{"issue":"8","key":"3589_CR89","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.3390\/ijms25084433","volume":"25","author":"S Fragiotta","year":"2024","unstructured":"Fragiotta S, Bassis L, Abdolrahimzadeh B, Marino A, Sepe M, Abdolrahimzadeh S. Exploring current molecular targets in the treatment of neovascular age-related macular degeneration toward the perspective of long-term agents. Int J Mol Sci. 2024;25(8):4433.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3589_CR90","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4161\/cam.1.2.4488","volume":"1","author":"AF Siekmann","year":"2007","unstructured":"Siekmann AF, Lawson ND. Notch signalling and the regulation of angiogenesis. Cell Adh Migr. 2007;1(2):104\u20136.","journal-title":"Cell Adh Migr"},{"issue":"3","key":"3589_CR91","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4161\/cam.1.3.4978","volume":"1","author":"M Hellstrom","year":"2007","unstructured":"Hellstrom M, Phng LK, Gerhardt H. VEGF and Notch signaling: the yin and yang of angiogenic sprouting. Cell Adh Migr. 2007;1(3):133\u20136.","journal-title":"Cell Adh Migr"},{"issue":"8","key":"3589_CR92","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/ncb3574","volume":"19","author":"SS Hasan","year":"2017","unstructured":"Hasan SS, Tsaryk R, Lange M, Wisniewski L, Moore JC, Lawson ND, Wojciechowska K, Schnittler H, Siekmann AF. Endothelial Notch signalling limits angiogenesis via control of artery formation. Nat Cell Biol. 2017;19(8):928\u201340.","journal-title":"Nat Cell Biol"},{"issue":"8","key":"3589_CR93","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nrm.2017.36","volume":"18","author":"M Potente","year":"2017","unstructured":"Potente M, M\u00e4kinen T. Vascular heterogeneity and specialization in development and disease. Nat Rev Mol Cell Biol. 2017;18(8):477\u201394.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3589_CR94","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006569","volume":"3","author":"R Blanco","year":"2013","unstructured":"Blanco R, Gerhardt H. VEGF and Notch in tip and stalk cell selection. Cold Spring Harb Perspect Med. 2013;3(1): a006569.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"3589_CR95","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cell.2009.03.025","volume":"137","author":"R Benedito","year":"2009","unstructured":"Benedito R, Roca C, Sorensen I, Adams S, Gossler A, Fruttiger M, Adams RH. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell. 2009;137(6):1124\u201335.","journal-title":"Cell"},{"key":"3589_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123412","volume":"322","author":"F Jin","year":"2025","unstructured":"Jin F, Guan P, Huang L, Zhang A, Gao S, Wang L, Liu Z. DLL4\/VEGF bispecific molecularly imprinted nanomissile for robust tumor therapy. Biomaterials. 2025;322: 123412.","journal-title":"Biomaterials"},{"issue":"2","key":"3589_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2024.151420","volume":"103","author":"BJ Sreelakshmi","year":"2024","unstructured":"Sreelakshmi BJ, Karthika CL, Ahalya S, Kalpana SR, Kartha CC, Sumi S. Mechanoresponsive ETS1 causes endothelial dysfunction and arterialization in varicose veins via NOTCH4\/DLL4 signaling. Eur J Cell Biol. 2024;103(2): 151420.","journal-title":"Eur J Cell Biol"},{"issue":"1","key":"3589_CR98","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10555-023-10129-8","volume":"43","author":"SF Jawad","year":"2024","unstructured":"Jawad SF, Altalbawy FMA, Hussein RM, Fadhil AA, Jawad MA, Zabibah RS, Taraki TY, Mohan CD, Rangappa KS. The strict regulation of HIF-1\u03b1 by non-coding RNAs: new insight towards proliferation, metastasis, and therapeutic resistance strategies. Cancer Metastasis Rev. 2024;43(1):5\u201327.","journal-title":"Cancer Metastasis Rev"},{"key":"3589_CR99","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.omto.2021.04.002","volume":"21","author":"ZS Razavi","year":"2021","unstructured":"Razavi ZS, Asgarpour K, Mahjoubin-Tehran M, Rasouli S, Khan H, Shahrzad MK, Hamblin MR, Mirzaei H. Angiogenesis-related non-coding RNAs and gastrointestinal cancer. Mol Ther Oncolytics. 2021;21:220\u201341.","journal-title":"Mol Ther Oncolytics"},{"issue":"13","key":"3589_CR100","doi-asserted-by":"publisher","first-page":"6032","DOI":"10.1111\/jcmm.16460","volume":"25","author":"K Bassand","year":"2021","unstructured":"Bassand K, Metzinger L, Na\u00efm M, Mouhoubi N, Haddad O, Assoun V, Za\u00efdi N, Sainte-Catherine O, Butt A, Guyot E, Oudar O, Laguillier-Morizot C, Sutton A, Charnaux N, Metzinger-Le Meuth V, Hlawaty H. miR-126\u20133p is essential for CXCL12-induced angiogenesis. J Cell Mol Med. 2021;25(13):6032\u201345.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"3589_CR101","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s13287-022-03056-y","volume":"13","author":"Q Qu","year":"2022","unstructured":"Qu Q, Liu L, Cui Y, Liu H, Yi J, Bing W, Liu C, Jiang D, Bi Y. miR-126-3p containing exosomes derived from human umbilical cord mesenchymal stem cells promote angiogenesis and attenuate ovarian granulosa cell apoptosis in a preclinical rat model of premature ovarian failure. Stem Cell Res Ther. 2022;13(1):352.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"3589_CR102","doi-asserted-by":"publisher","first-page":"886","DOI":"10.4103\/IJO.IJO_1791_24","volume":"73","author":"I Akaray","year":"2025","unstructured":"Akaray I, Ozal SA, Sancar H, Ozal E, Ayaz L. miR-124, miR-126-3p, and miR-200b: potential therapeutic targets for VEGF-mediated complications in proliferative diabetic retinopathy. Indian J Ophthalmol. 2025;73(6):886\u201392. https:\/\/doi.org\/10.4103\/IJO.IJO_1791_24.","journal-title":"Indian J Ophthalmol"},{"issue":"7","key":"3589_CR103","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.3390\/cancers13071710","volume":"13","author":"E Conde","year":"2021","unstructured":"Conde E, Earl J, Crespo-Toro L, Blanco-Agudo C, Ramos-Mu\u00f1oz E, Rodr\u00edguez-Serrano EM, Mart\u00ednez \u00c1vila JC, Salinas-Mu\u00f1oz L, Serrano-Huertas S, Ferreiro R, Rodriguez-Garrote M, Sainz B Jr, Massuti B, Alfonso PG, Benavides M, Aranda E, Garc\u00eda-Bermejo ML, Carrato A. Biomarkers associated with regorafenib first-line treatment benefits in metastatic colorectal cancer patients: REFRAME molecular study. Cancers (Basel). 2021;13(7):1710.","journal-title":"Cancers (Basel)."},{"issue":"17","key":"3589_CR104","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.3390\/cells11172651","volume":"11","author":"W Xue","year":"2022","unstructured":"Xue W, Zhang Q, Chen Y, Zhu Y. Hydrogen sulfide improves angiogenesis by regulating the transcription of pri-miR-126 in diabetic endothelial cells. Cells. 2022;11(17):2651.","journal-title":"Cells"},{"issue":"4","key":"3589_CR105","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1515\/dx-2022-0036","volume":"9","author":"K Akp\u0131nar","year":"2022","unstructured":"Akp\u0131nar K, Aslan D, Fenk\u00e7i SM, Caner V. miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy. Diagnosis (Berl). 2022;9(4):499\u2013507.","journal-title":"Diagnosis (Berl)"},{"issue":"1","key":"3589_CR106","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","volume":"19","author":"S Gurung","year":"2021","unstructured":"Gurung S, Perocheau D, Touramanidou L, Baruteau J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal. 2021;19(1):47.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"3589_CR107","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-019-0963-9","volume":"18","author":"KM McAndrews","year":"2019","unstructured":"McAndrews KM, Kalluri R. Mechanisms associated with biogenesis of exosomes in cancer. Mol Cancer. 2019;18(1):52.","journal-title":"Mol Cancer"},{"issue":"5","key":"3589_CR108","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/membranes12050498","volume":"12","author":"S Xie","year":"2022","unstructured":"Xie S, Zhang Q, Jiang L. Current knowledge on exosome biogenesis, cargo-sorting mechanism and therapeutic implications. Membranes. 2022;12(5):498.","journal-title":"Membranes"},{"key":"3589_CR109","doi-asserted-by":"publisher","DOI":"10.1063\/1.5087122","volume":"3","author":"X Li","year":"2019","unstructured":"Li X, Corbett A, Taatizadeh E, Tasnim N, Little J, Garnis C, Daugaard M, Guns E, Hoorfar M, Li I. Challenges and opportunities in exosome research\u2014perspectives from biology, engineering, and cancer therapy. APL Bioeng. 2019;3: 011503.","journal-title":"APL Bioeng."},{"key":"3589_CR110","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13287-019-1297-7","volume":"10","author":"M Xu","year":"2019","unstructured":"Xu M, Ye Z, Song X-T, Huang R-C. Differences in the cargos and functions of exosomes derived from six cardiac cell types: a systematic review. Stem Cell Res Ther. 2019;10:194.","journal-title":"Stem Cell Res Ther"},{"key":"3589_CR111","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu V. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.","journal-title":"Science"},{"key":"3589_CR112","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/cells8020099","volume":"8","author":"A Jan","year":"2019","unstructured":"Jan A, Rahman S, Khan S, Tasduq S, Choi I. Biology, pathophysiological role, and clinical implications of exosomes: a critical appraisal. Cells. 2019;8:99.","journal-title":"Cells"},{"key":"3589_CR113","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/tra.12687","volume":"20","author":"M Vidal","year":"2019","unstructured":"Vidal M. Exosomes: revisiting their role as \u201cgarbage bags.\u201d Traffic. 2019;20:815\u201328.","journal-title":"Traffic"},{"issue":"1","key":"3589_CR114","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12964-024-01999-8","volume":"23","author":"S Wessler","year":"2025","unstructured":"Wessler S, Meisner-Kober N. On the road: extracellular vesicles in intercellular communication. Cell Commun Signal. 2025;23(1):95.","journal-title":"Cell Commun Signal"},{"key":"3589_CR115","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019;9:19.","journal-title":"Cell Biosci"},{"issue":"5","key":"3589_CR116","doi-asserted-by":"publisher","first-page":"e51475","DOI":"10.15252\/embr.202051475","volume":"22","author":"T Matsui","year":"2021","unstructured":"Matsui T, Osaki F, Hiragi S, Sakamaki Y, Fukuda M. ALIX and ceramide differentially control polarized small extracellular vesicle release from epithelial cells. Embo Rep. 2021;22(5):e51475.","journal-title":"Embo Rep"},{"issue":"1","key":"3589_CR117","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/imm.13561","volume":"168","author":"A Singh","year":"2022","unstructured":"Singh A, Das K, Banerjee S, Sen P. Elucidation of the signalling pathways for enhanced exosome release from Mycobacterium-infected macrophages and subsequent induction of differentiation. Immunology. 2022;168(1):63\u201382.","journal-title":"Immunology"},{"issue":"2","key":"3589_CR118","doi-asserted-by":"publisher","first-page":"777","DOI":"10.4049\/jimmunol.1103638","volume":"189","author":"P Singh","year":"2012","unstructured":"Singh P, Smith V, Karakousis PC, Schorey JS. Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo. J Immunol. 2012;189(2):777\u201385.","journal-title":"J Immunol"},{"key":"3589_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-025-01621-0","author":"DK Jeppesen","year":"2025","unstructured":"Jeppesen DK, Sanchez ZC, Kelley NM, Hayes JB, Ambroise J, Koory EN, Krystofiak E, Taneja N, Zhang Q, Dungan MM, Perkins OL, Tyska MJ, Knapik EW, Dean KM, Doran AC, Coffey RJ, Burnette DT. Blebbisomes are large, organelle-rich extracellular vesicles with cell-like properties. Nat Cell Biol. 2025. https:\/\/doi.org\/10.1038\/s41556-025-01621-0.","journal-title":"Nat Cell Biol"},{"issue":"7","key":"3589_CR120","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/tra.12803","volume":"22","author":"J Donoso-Quezada","year":"2021","unstructured":"Donoso-Quezada J, Ayala-Mar S, Gonzalez-Valdez J. The role of lipids in exosome biology and intercellular communication: function, analytics and applications. Traffic. 2021;22(7):204\u201320.","journal-title":"Traffic"},{"issue":"4","key":"3589_CR121","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","volume":"56","author":"YJ Lee","year":"2024","unstructured":"Lee YJ, Shin KJ, Chae YC. Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer. Exp Mol Med. 2024;56(4):877\u201389.","journal-title":"Exp Mol Med"},{"issue":"17","key":"3589_CR122","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.3390\/cancers13174435","volume":"13","author":"HS Kim","year":"2021","unstructured":"Kim HS, Jang H, Cho H, Choi J, Hwang KY, Choi Y, Kim SH, Yang Y. Recent advances in exosome-based drug delivery for cancer therapy. Cancers. 2021;13(17):4435.","journal-title":"Cancers"},{"key":"3589_CR123","doi-asserted-by":"publisher","first-page":"7289","DOI":"10.3390\/molecules27217289","volume":"27","author":"A Rajput","year":"2022","unstructured":"Rajput A, Varshney A, Bajaj R, Pokharkar V. Exosomes as new generation vehicles for drug delivery: biomedical applications and future perspectives. Molecules. 2022;27:7289.","journal-title":"Molecules"},{"key":"3589_CR124","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.biomaterials.2019.01.016","volume":"197","author":"B Mathew","year":"2019","unstructured":"Mathew B, Ravindran S, Liu X, Torres L, Chennakesavalu M, Huang CC, Feng L, Zelka R, Lopez J, Sharma M, Roth S. Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion. Biomaterials. 2019;197:146\u201360.","journal-title":"Biomaterials"},{"key":"3589_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121484","volume":"284","author":"Z Yu","year":"2022","unstructured":"Yu Z, Wen Y, Jiang N, Li Z, Guan J, Zhang Y, Deng C, Zhao L, Zheng SG, Zhu Y, Su W, Zhuo Y. TNF-\u03b1 stimulation enhances the neuroprotective effects of gingival MSCs derived exosomes in retinal ischemia-reperfusion injury via the MEG3\/miR-21a-5p axis. Biomaterials. 2022;284: 121484.","journal-title":"Biomaterials"},{"issue":"2","key":"3589_CR126","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/ijms22020829","volume":"22","author":"SL Elshaer","year":"2021","unstructured":"Elshaer SL, Park HS, Pearson L, Hill WD, Longo FM, El-Remessy AB. Modulation of p75(NTR) on mesenchymal stem cells increases their vascular protection in retinal ischemia-reperfusion mouse model. Int J Mol Sci. 2021;22(2):829.","journal-title":"Int J Mol Sci"},{"key":"3589_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.956563","volume":"10","author":"A Dalmizrak","year":"2022","unstructured":"Dalmizrak A, Dalm\u0131zrak \u00d6. Mesenchymal Stem Cell-Derived Exosomes as New Tools for Delivery of miRNAs in the Treatment of Cancer. Front Bioeng Biotechnol. 2022;10: 956563.","journal-title":"Front Bioeng Biotechnol."},{"issue":"8","key":"3589_CR128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255822","volume":"16","author":"JA Gim","year":"2021","unstructured":"Gim JA, Bang SM, Lee YS, Yim SY, Jung YK, Kim H, Kim B-H, Kim JH, Seo YS, Yim HJ, Yeon JE, Um SH, Byun KS. Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression. PLoS ONE. 2021;16(8): e0255822.","journal-title":"PLoS ONE"},{"key":"3589_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.650426","volume":"9","author":"H Song","year":"2021","unstructured":"Song H, Liu B, Dong B, Xu J, Zhou H, Sha N, Liu Y, Pan Y, Chen F, Li L, Wang J. Exosome-based delivery of natural products in cancer therapy. Front Cell Dev Biol. 2021;9: 650426.","journal-title":"Front Cell Dev Biol"},{"key":"3589_CR130","doi-asserted-by":"publisher","first-page":"5093","DOI":"10.2147\/JIR.S457978","volume":"17","author":"Q Wu","year":"2024","unstructured":"Wu Q. Tumor cell-derived exosomal hybrid nanosystems loaded with rhubarbic acid and Tanshinone IIA for sepsis treatment. J Inflamm Res. 2024;17:5093\u2013112.","journal-title":"J Inflamm Res"},{"issue":"6","key":"3589_CR131","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/pharmaceutics14061118","volume":"14","author":"H Choi","year":"2022","unstructured":"Choi H, Kim M-Y, Kim D-H, Yun H, Oh B-K, Kim S-B, Song I, Park H-S, Kim SE, Park C, Choi C. Quantitative biodistribution and pharmacokinetics study of gmp-grade exosomes labeled with 89Zr radioisotope in mice and rats. Pharmaceutics. 2022;14(6):1118.","journal-title":"Pharmaceutics"},{"issue":"11","key":"3589_CR132","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.3390\/ijms21114072","volume":"21","author":"L Hofmann","year":"2020","unstructured":"Hofmann L, Ludwig S, Vahl JM, Brunner C, Hoffmann T, Theodoraki MN. The emerging role of exosomes in diagnosis, prognosis, and therapy in head and neck cancer. IJMS. 2020;21(11):4072.","journal-title":"IJMS"},{"key":"3589_CR133","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.apsb.2021.01.001","volume":"11","author":"J-Y Liu","year":"2021","unstructured":"Liu J-Y, Ren L-W, Li S, Li W, Zheng X-J, Yang Y, Fu W, Yi J, Wang J, Du G. The biology, function, and applications of exosomes in cancer. Acta Pharmaceutica Sinica B. 2021;11:2783\u201397.","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"4","key":"3589_CR134","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","volume":"56","author":"HI Kim","year":"2024","unstructured":"Kim HI, Park J, Zhu Y, Wang X, Han Y, Zhang D. Recent advances in extracellular vesicles for therapeutic cargo delivery. Exp Mol Med. 2024;56(4):836\u201349.","journal-title":"Exp Mol Med"},{"issue":"1","key":"3589_CR135","first-page":"233","volume":"13","author":"N Blanco-Agudin","year":"2025","unstructured":"Blanco-Agudin N, Ye S, Gonzalez-Fernandez S, Alcalde I, Merayo-Lloves J, Quiros LM. Exosomes in ocular health: recent insights into pathology. Diagn Appl Therap Funct Biomed. 2025;13(1):233.","journal-title":"Diagn Appl Therap Funct Biomed"},{"issue":"4","key":"3589_CR136","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.scib.2023.12.037","volume":"69","author":"M Pan","year":"2024","unstructured":"Pan M, Zhang Z, Wang Q, Shang L. Exosome-loaded microcarriers for intraocular drug delivery. Sci Bull (Beijing). 2024;69(4):434\u20136.","journal-title":"Sci Bull (Beijing)"},{"key":"3589_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114899","volume":"199","author":"Y Tian","year":"2023","unstructured":"Tian Y, Zhang T, Li J, Tao Y. Advances in development of exosomes for ophthalmic therapeutics. Adv Drug Deliv Rev. 2023;199: 114899.","journal-title":"Adv Drug Deliv Rev"},{"key":"3589_CR138","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.2147\/IJN.S264498","volume":"15","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Bi JY, Huang J, Tang YN, Du S, Li P. Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomed. 2020;15:6917\u201334.","journal-title":"Int J Nanomed"},{"issue":"4","key":"3589_CR139","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/cells8040307","volume":"8","author":"S Gurunathan","year":"2019","unstructured":"Gurunathan S, Kang MH, Jeyaraj M, Qasim M, Kim JH. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells. 2019;8(4):307.","journal-title":"Cells"},{"key":"3589_CR140","doi-asserted-by":"publisher","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","volume":"16","author":"R Tenchov","year":"2022","unstructured":"Tenchov R, Sasso J, Wang X, Liaw W, Chen C-A, Zhou Q. Exosomes\u2014nature\u2019s lipid nanoparticles, a rising star in drug delivery and diagnostics. ACS Nano. 2022;16:17802\u201346.","journal-title":"ACS Nano"},{"issue":"9","key":"3589_CR141","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41551-021-00764-3","volume":"5","author":"Y Tian","year":"2021","unstructured":"Tian Y, Zhang F, Qiu Y, Wang S, Li F, Zhao J, Pan C, Tao Y, Yu D, Wei W. Reduction of choroidal neovascularization via cleavable VEGF antibodies conjugated to exosomes derived from regulatory T cells. Nat Biomed Eng. 2021;5(9):968\u201382.","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"3589_CR142","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s10020-025-01120-w","volume":"31","author":"W An","year":"2025","unstructured":"An W, Zhang W, Qi J, Xu W, Long Y, Qin H, Yao K. Mesenchymal stem cells and mesenchymal stem cell-derived exosomes: a promising strategy for treating retinal degenerative diseases. Mol Med. 2025;31(1):75.","journal-title":"Mol Med"},{"issue":"1","key":"3589_CR143","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/s12935-021-02157-7","volume":"21","author":"W Zhou","year":"2021","unstructured":"Zhou W, Xu M, Wang Z, Yang M. Engineered exosomes loaded with miR-449a selectively inhibit the growth of homologous non-small cell lung cancer. Cancer Cell Int. 2021;21(1):485.","journal-title":"Cancer Cell Int"},{"key":"3589_CR144","doi-asserted-by":"publisher","first-page":"24692","DOI":"10.3402\/jev.v3.24692","volume":"3","author":"MT Aatonen","year":"2014","unstructured":"Aatonen MT, Ohman T, Nyman TA, Laitinen S, Gronholm M, Siljander PR. Isolation and characterization of platelet-derived extracellular vesicles. J Extracell Vesicles. 2014;3:24692.","journal-title":"J Extracell Vesicles."},{"issue":"40","key":"3589_CR145","doi-asserted-by":"publisher","first-page":"10584","DOI":"10.1073\/pnas.1709210114","volume":"114","author":"M Wu","year":"2017","unstructured":"Wu M, Ouyang Y, Wang Z, Zhang R, Huang PH, Chen C, Li H, Li P, Quinn D, Dao M, Suresh S, Sadovsky Y, Huang TJ. Isolation of exosomes from whole blood by integrating acoustics and microfluidics. Proc Natl Acad Sci USA. 2017;114(40):10584\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3589_CR146","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cca.2019.02.021","volume":"493","author":"BY Chen","year":"2019","unstructured":"Chen BY, Sung CW, Chen C, Cheng CM, Lin DP, Huang CT, Hsu MY. Advances in exosomes technology. Clin Chim Acta. 2019;493:14\u20139.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"3589_CR147","doi-asserted-by":"publisher","first-page":"834","DOI":"10.3892\/ijmm.2017.3080","volume":"40","author":"YT Tang","year":"2017","unstructured":"Tang YT, Huang YY, Zheng L, Qin SH, Xu XP, An TX, Xu Y, Wu YS, Hu XM, Ping BH, Wang Q. Comparison of isolation methods of exosomes and exosomal RNA from cell culture medium and serum. Int J Mol Med. 2017;40(3):834\u201344.","journal-title":"Int J Mol Med"},{"issue":"10","key":"3589_CR148","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3390\/mi13101571","volume":"13","author":"Y Wu","year":"2022","unstructured":"Wu Y, Wang Y, Lu Y, Luo X, Huang Y, Xie T, Pilarsky C, Dang Y, Zhang J. Microfluidic technology for the isolation and analysis of exosomes. Micromachines (Basel). 2022;13(10):1571.","journal-title":"Micromachines (Basel)"},{"issue":"11","key":"3589_CR149","doi-asserted-by":"publisher","first-page":"17047","DOI":"10.1021\/acsnano.1c03469","volume":"15","author":"S Hassanpour Tamrin","year":"2021","unstructured":"Hassanpour Tamrin S, Sanati Nezhad A, Sen A. Label-free isolation of exosomes using microfluidic technologies. ACS Nano. 2021;15(11):17047\u201379.","journal-title":"ACS Nano"},{"key":"3589_CR150","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-1-0716-3995-5_17","volume":"2835","author":"S Singh","year":"2024","unstructured":"Singh S, Dansby C, Agarwal D, Bhat PD, Dubey PK, Krishnamurthy P. Exosomes: methods for isolation and characterization in biological samples. Methods Mol Biol. 2024;2835:181\u2013213.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"3589_CR151","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13367","volume":"85","author":"S Tiwari","year":"2021","unstructured":"Tiwari S, Kumar V, Randhawa S, Verma SK. Preparation and characterization of extracellular vesicles. Am J Reprod Immunol. 2021;85(2): e13367.","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"3589_CR152","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Thery","year":"2018","unstructured":"Thery C, Witwer KW, Aikawa E. Minimal information for studies of extracellular vesicles 2018 (MISEV2018) a position statement of the International society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.","journal-title":"J Extracell Vesicles."},{"issue":"3","key":"3589_CR153","doi-asserted-by":"publisher","DOI":"10.1088\/1748-605X\/ad3310","volume":"19","author":"W Yin","year":"2024","unstructured":"Yin W. Targeted exosome-based nanoplatform for new-generation therapeutic strategies. Biomed Mater. 2024;19(3): 032002.","journal-title":"Biomed Mater"},{"issue":"1","key":"3589_CR154","doi-asserted-by":"publisher","first-page":"8278","DOI":"10.1038\/s41598-019-44569-6","volume":"9","author":"M Khongkow","year":"2019","unstructured":"Khongkow M, Yata T, Boonrungsiman S, Ruktanonchai U, Graham D, Namdee K. Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood\u2013brain barrier penetration. Sci Rep. 2019;9(1):8278.","journal-title":"Sci Rep"},{"issue":"10","key":"3589_CR155","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3390\/biology11101483","volume":"11","author":"D Ge\u010dys","year":"2022","unstructured":"Ge\u010dys D, Kazlauskas A, Ge\u010dyt\u0117 E, Pau\u017eien\u0117 N, Kulakauskien\u0117 D, Lukminait\u0117 I, Jekabsone A. Internalisation of RGD-engineered extracellular vesicles by glioblastoma cells. Biology. 2022;11(10):1483.","journal-title":"Biology"},{"issue":"12","key":"3589_CR156","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1167\/iovs.18-24803","volume":"59","author":"R Samaeekia","year":"2018","unstructured":"Samaeekia R, Rabiee B, Putra I, Shen X, Park YJ, Hematti P, Eslani M, Djalilian AR. Effect of human corneal mesenchymal stromal cell-derived exosomes on corneal epithelial wound healing. Investig Opthalmol Visual Sci. 2018;59(12):5194.","journal-title":"Investig Opthalmol Visual Sci"},{"issue":"7","key":"3589_CR157","doi-asserted-by":"publisher","first-page":"776","DOI":"10.4252\/wjsc.v13.i7.776","volume":"13","author":"A Nasirishargh","year":"2021","unstructured":"Nasirishargh A, Kumar P, Ramasubramanian L, Clark KC, Hao D, Lazar SV, Wang A. Exosomal microRNAs from mesenchymal stem\/stromal cells: biology and applications in neuroprotection. World J Stem Cells. 2021;13(7):776\u201394.","journal-title":"World J Stem Cells"},{"key":"3589_CR158","doi-asserted-by":"publisher","first-page":"8278","DOI":"10.1016\/j.vesic.2024.100052","volume":"4","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wang L, Yu X, Mao W, Wan Y. Ultrasonication outperforms electroporation for extracellular vesicle cargo depletion. Extracell Vesicle. 2024;4:8278.","journal-title":"Extracell Vesicle."},{"issue":"10","key":"3589_CR159","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1021\/acsbiomaterials.4c00856","volume":"10","author":"W Ahmed","year":"2024","unstructured":"Ahmed W, Mushtaq A, Ali S, Khan N, Liang Y, Duan L. Engineering approaches for exosome cargo loading and targeted delivery: biological versus chemical perspectives. ACS Biomater Sci Eng. 2024;10(10):5960\u201376. https:\/\/doi.org\/10.1021\/acsbiomaterials.4c00856.","journal-title":"ACS Biomater Sci Eng"},{"issue":"1","key":"3589_CR160","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40659-025-00591-9","volume":"58","author":"A Szewczyk","year":"2025","unstructured":"Szewczyk A, Rembialkowska N, Saczko J, Daczewska M, Novickij V, Kulbacka J. Calcium electroporation induces stress response through upregulation of HSP27, HSP70, aspartate beta-hydroxylase, and CD133 in human colon cancer cells. Biol Res. 2025;58(1):10.","journal-title":"Biol Res"},{"issue":"30","key":"3589_CR161","doi-asserted-by":"publisher","first-page":"7384","DOI":"10.1039\/D4TB00849A","volume":"12","author":"HA Millan Cotto","year":"2024","unstructured":"Millan Cotto HA, Pathrikar TV, Hakim B, Baby HM, Zhang H, Zhao P, Ansaripour R, Amini R, Carrier RL, Bajpayee AG. Cationic-motif-modified exosomes for mRNA delivery to retinal photoreceptors. J Mater Chem B. 2024;12(30):7384\u2013400. https:\/\/doi.org\/10.1039\/D4TB00849A.","journal-title":"J Mater Chem B"},{"issue":"5","key":"3589_CR162","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s10616-016-9952-7","volume":"68","author":"KB Johnsen","year":"2016","unstructured":"Johnsen KB, Gudbergsson JM, Skov MN, Christiansen G, Gurevich L, Moos T, Duroux M. Evaluation of electroporation-induced adverse effects on adipose-derived stem cell exosomes. Cytotechnology. 2016;68(5):2125\u201338.","journal-title":"Cytotechnology"},{"issue":"10","key":"3589_CR163","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3390\/cells12101416","volume":"12","author":"H Zeng","year":"2023","unstructured":"Zeng H, Guo S, Ren X, Wu Z, Liu S, Yao X. Current strategies for exosome cargo loading and targeting delivery. Cells. 2023;12(10):1416.","journal-title":"Cells"},{"issue":"9","key":"3589_CR164","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.3390\/cells10092413","volume":"10","author":"ZA Nizamudeen","year":"2021","unstructured":"Nizamudeen ZA, Xerri R, Parmenter C, Suain K, Markus R, Chakrabarti L, Sottile V. Low-power sonication can alter extracellular vesicle size and properties. Cells. 2021;10(9):2413.","journal-title":"Cells"},{"issue":"8","key":"3589_CR165","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.3390\/pharmaceutics15082042","volume":"15","author":"HB Koh","year":"2023","unstructured":"Koh HB, Kim HJ, Kang SW, Yoo TH. Exosome-based drug delivery: translation from bench to clinic. Pharmaceutics. 2023;15(8):2402.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3589_CR166","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1186\/s12967-025-06578-0","volume":"23","author":"C Liu","year":"2025","unstructured":"Liu C, Cheng C, Cheng K, Gao AS, Li Q, Atala A, Zhang Y. Precision exosome engineering for enhanced wound healing and scar revision. J Transl Med. 2025;23(1):578.","journal-title":"J Transl Med"},{"issue":"1","key":"3589_CR167","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12951-025-03095-6","volume":"23","author":"Z Tang","year":"2025","unstructured":"Tang Z, Ye F, Ni N, Fan X, Lu L, Gu P. Frontier applications of retinal nanomedicine: progress, challenges and perspectives. J Nanobiotechnology. 2025;23(1):143.","journal-title":"J Nanobiotechnology"},{"key":"3589_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2020.01.057","volume":"321","author":"C Jumelle","year":"2020","unstructured":"Jumelle C, Gholizadeh S, Annabi N, Dana R. Advances and limitations of drug delivery systems formulated as eye drops. J Control Release. 2020;321:1\u201322.","journal-title":"J Control Release"},{"key":"3589_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150212","volume":"723","author":"H Yang","year":"2024","unstructured":"Yang H, Wu P, Wang T, Yu Y, Li J, Liu R, Ruan Q. Topical ophthalmic instillation of engineered hMSCs-derived exosomes: a novel non-invasive therapeutic strategy for ocular posterior-segment disorder. Biochem Biophys Res Commun. 2024;723: 150212.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"3589_CR170","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/ACI.0b013e3283645899","volume":"13","author":"F Mantelli","year":"2013","unstructured":"Mantelli F, Mauris J, Arg\u00fceso P. The ocular surface epithelial barrier and other mechanisms of mucosal protection: from allergy to infectious diseases. Curr Opin Allergy Clin Immunol. 2013;13(5):563\u20138.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"3589_CR171","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13010122","author":"RO Elliott","year":"2021","unstructured":"Elliott RO, He M. Unlocking the power of exosomes for crossing biological barriers in drug delivery. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13010122.","journal-title":"Pharmaceutics"},{"key":"3589_CR172","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.643680","volume":"9","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Mugisha A, Fransisca S, Liu Q, Xie P, Hu Z. Emerging role of exosomes in retinal diseases. Front Cell Dev Biol. 2021;9: 643680.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"3589_CR173","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12951-025-03352-8","volume":"23","author":"S Mehdizadeh","year":"2025","unstructured":"Mehdizadeh S, Mamaghani M, Hassanikia S, Pilehvar Y, Ertas YN. Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies. J Nanobiotechnol. 2025;23(1):329.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"3589_CR174","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12929-024-01036-3","volume":"31","author":"B Martins","year":"2024","unstructured":"Martins B, Pires M, Ambr\u00f3sio AF, Gir\u00e3o H, Fernandes R. Contribution of extracellular vesicles for the pathogenesis of retinal diseases: shedding light on blood-retinal barrier dysfunction. J Biomed Sci. 2024;31(1):48.","journal-title":"J Biomed Sci"},{"issue":"12","key":"3589_CR175","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00210-022-02287-3","volume":"395","author":"M Tawfik","year":"2022","unstructured":"Tawfik M, Chen F, Goldberg JL, Sabel BA. Nanomedicine and drug delivery to the retina: current status and implications for gene therapy. Naunyn Schmiedebergs Arch Pharmacol. 2022;395(12):1477\u2013507.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3589_CR176","doi-asserted-by":"publisher","first-page":"1100310","DOI":"10.3389\/fbioe.2023.1100310","volume":"11","author":"X Feng","year":"2023","unstructured":"Feng X, Peng Z, Yuan L, Jin M, Hu H, Peng X, Wang Y, Zhang C, Luo Z, Liao H. Research progress of exosomes in pathogenesis, diagnosis, and treatment of ocular diseases. Front Bioeng Biotechnol. 2023;11:1100310.","journal-title":"Front Bioeng Biotechnol"},{"key":"3589_CR177","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","volume":"57","author":"EM Del Amo","year":"2017","unstructured":"Del Amo EM, Rimpel\u00e4 AK, Heikkinen E, Kari OK, Ramsay E, Lajunen T, Schmitt M, Pelkonen L, Bhattacharya M, Richardson D, Subrizi A, Turunen T, Reinisalo M, Itkonen J, Toropainen E, Casteleijn M, Kidron H, Antopolsky M, Vellonen KS, Ruponen M, Urtti A. Pharmacokinetic aspects of retinal drug delivery. Prog Retin Eye Res. 2017;57:134\u201385.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"3589_CR178","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10787-022-01115-7","volume":"31","author":"S Sadeghi","year":"2023","unstructured":"Sadeghi S, Tehrani FR, Tahmasebi S, Shafiee A, Hashemi SM. Exosome engineering in cell therapy and drug delivery. Inflammopharmacology. 2023;31(1):145\u201369.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"3589_CR179","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41598-023-28215-w","volume":"13","author":"A Muniyandi","year":"2023","unstructured":"Muniyandi A, Martin M, Sishtla K, Motolani A, Sun M, Jensen NR, Qi X, Boulton ME, Prabhu L, Lu T, Corson TW. PRMT5 is a therapeutic target in choroidal neovascularization. Sci Rep. 2023;13(1):1747.","journal-title":"Sci Rep"},{"issue":"1","key":"3589_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10456-024-09954-4","volume":"28","author":"S Tzaridis","year":"2024","unstructured":"Tzaridis S, Aguilar E, Dorrell MI, Friedlander M, Eade KT. Retinal pigment epithelial cells reduce vascular leak and proliferation in retinal neovessels. Angiogenesis. 2024;28(1):1.","journal-title":"Angiogenesis"},{"issue":"16","key":"3589_CR181","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.3390\/cells11162573","volume":"11","author":"D Pollalis","year":"2022","unstructured":"Pollalis D, Kim D, Nair GKG, Kang C, Nanda AV, Lee SY. Intraocular RGD-engineered exosomes and active targeting of choroidal neovascularization (CNV). Cells. 2022;11(16):2573.","journal-title":"Cells"},{"key":"3589_CR182","doi-asserted-by":"publisher","first-page":"1412138","DOI":"10.3389\/fendo.2024.1412138","volume":"15","author":"H Zhao","year":"2024","unstructured":"Zhao H, Cai Y, Pan J, Chen Q. Role of microRNA in linking diabetic retinal neurodegeneration and vascular degeneration. Front Endocrinol (Lausanne). 2024;15:1412138.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3589_CR183","volume":"22","author":"A Fukushima","year":"2020","unstructured":"Fukushima A, Takahashi E, Saruwatari J, Tanihara H, Inoue T. The angiogenic effects of exosomes secreted from retinal pigment epithelial cells on endothelial cells. Biochem Biophys Rep. 2020;22: 100760.","journal-title":"Biochem Biophys Rep"},{"issue":"10","key":"3589_CR184","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1167\/iovs.15-18353","volume":"57","author":"JE Knickelbein","year":"2016","unstructured":"Knickelbein JE, Liu B, Arakelyan A, Zicari S, Hannes S, Chen P, Li Z, Grivel JC, Chaigne-Delalande B, Sen HN, Margolis L, Nussenblatt RB. Modulation of immune responses by extracellular vesicles from retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2016;57(10):4101\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"3589_CR185","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41419-024-06659-w","volume":"15","author":"YR Jiao","year":"2024","unstructured":"Jiao YR, Chen KX, Tang X, Tang YL, Yang HL, Yin YL, Li CJ. Exosomes derived from mesenchymal stem cells in diabetes and diabetic complications. Cell Death Dis. 2024;15(4):271.","journal-title":"Cell Death Dis"},{"issue":"4","key":"3589_CR186","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3390\/pharmaceutics15041167","volume":"15","author":"KY Wu","year":"2023","unstructured":"Wu KY, Ahmad H, Lin G, Carbonneau M, Tran SD. Mesenchymal Stem Cell-Derived Exosomes in Ophthalmology: A Comprehensive Review. Pharmaceutics. 2023;15(4):1167.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3589_CR187","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12943-025-02372-0","volume":"24","author":"JJJ Liu","year":"2025","unstructured":"Liu JJJ, Liu D, To SKY, Wong AST. Exosomes in cancer nanomedicine: biotechnological advancements and innovations. Mol Cancer. 2025;24(1):166.","journal-title":"Mol Cancer"},{"issue":"1","key":"3589_CR188","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/10717544.2020.1870584","volume":"28","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang Q, Yang G, Wei Y, Li M, Du E, Li H, Song Z, Tao Y. RPE-derived exosomes rescue the photoreceptors during retina degeneration: an intraocular approach to deliver exosomes into the subretinal space. Drug Deliv. 2021;28(1):218\u201328.","journal-title":"Drug Deliv"},{"key":"3589_CR189","doi-asserted-by":"publisher","first-page":"10767","DOI":"10.2147\/IJN.S475234","volume":"19","author":"Y Song","year":"2024","unstructured":"Song Y, Yin C, Kong N. Stem cell-derived exosomes: natural intercellular messengers with versatile mechanisms for the treatment of diabetic retinopathy. Int J Nanomedicine. 2024;19:10767\u201384.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"3589_CR190","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s11671-025-04234-6","volume":"20","author":"RD Bairagi","year":"2025","unstructured":"Bairagi RD, Reon RR, Hasan MM, Sarker S, Debnath D, Rahman MT, Rahman S, Islam MA, Siddique MAT, Bokshi B, Rahman MM, Acharzo AK. Ocular drug delivery systems based on nanotechnology: a comprehensive review for the treatment of eye diseases. Discov Nano. 2025;20(1):75.","journal-title":"Discov Nano"},{"issue":"7","key":"3589_CR191","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12248","volume":"11","author":"X Liang","year":"2022","unstructured":"Liang X, Niu Z, Galli V, Howe N, Zhao Y, Wiklander OPB, Zheng W, Wiklander RJ, Corso G, Davies C, Hean J, Kyriakopoulou E, Mamand DR, Amin R, Nordin JZ, Gupta D, Andaloussi SE. Extracellular vesicles engineered to bind albumin demonstrate extended circulation time and lymph node accumulation in mouse models. J Extracell Vesicles. 2022;11(7): e12248.","journal-title":"J Extracell Vesicles"},{"key":"3589_CR192","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jare.2021.01.001","volume":"31","author":"N Parada","year":"2021","unstructured":"Parada N, Romero-Trujillo A, Georges N, Alcayaga-Miranda F. Camouflage strategies for therapeutic exosomes evasion from phagocytosis. J Adv Res. 2021;31:61\u201374.","journal-title":"J Adv Res"},{"issue":"Suppl 9","key":"3589_CR193","doi-asserted-by":"publisher","first-page":"S1406","DOI":"10.21037\/tcr.2017.10.32","volume":"6","author":"TL Whiteside","year":"2017","unstructured":"Whiteside TL. Therapeutic targeting of oncogenic KRAS in pancreatic cancer by engineered exosomes. Transl Cancer Res. 2017;6(Suppl 9):S1406-s1408.","journal-title":"Transl Cancer Res"},{"issue":"11","key":"3589_CR194","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/s41551-023-01112-3","volume":"8","author":"H Bao","year":"2024","unstructured":"Bao H, Tian Y, Wang H, Ye T, Wang S, Zhao J, Qiu Y, Li J, Pan C, Ma G, Wei W, Tao Y. Exosome-loaded degradable polymeric microcapsules for the treatment of vitreoretinal diseases. Nat Biomed Eng. 2024;8(11):1436\u201352.","journal-title":"Nat Biomed Eng"},{"issue":"3","key":"3589_CR195","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3892\/ijmm.2025.5484","volume":"55","author":"X Chen","year":"2025","unstructured":"Chen X, Tian B, Wang Y, Zheng J, Kang X. Potential and challenges of utilizing exosomes in osteoarthritis therapy (review). Int J Mol Med. 2025;55(3):43.","journal-title":"Int J Mol Med"},{"issue":"3","key":"3589_CR196","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v17.i3.101857","volume":"17","author":"JX Geng","year":"2025","unstructured":"Geng JX, Lu YF, Zhou JN, Huang B, Qin Y. Exosome technology: a novel and effective drug delivery system in the field of cancer therapy. World J Gastrointest Oncol. 2025;17(3): 101857.","journal-title":"World J Gastrointest Oncol"},{"issue":"6","key":"3589_CR197","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s11010-023-04798-w","volume":"479","author":"X Peng","year":"2024","unstructured":"Peng X, Zhang T, Liu R, Jin X. Potential in exosome-based targeted nano-drugs and delivery vehicles for posterior ocular disease treatment: from barriers to therapeutic application. Mol Cell Biochem. 2024;479(6):1319\u201333.","journal-title":"Mol Cell Biochem"},{"key":"3589_CR198","doi-asserted-by":"publisher","DOI":"10.1177\/24741264241280597","author":"J Grad","year":"2024","unstructured":"Grad J, Hatamnejad A, Dadak R, Sodhi S, Pattathil N, Choudhry N. Anti-VEGF monotherapy vs anti-VEGF and steroid combination therapy for diabetic macular edema: a meta-analysis. J Vitreoretin Dis. 2024. https:\/\/doi.org\/10.1177\/24741264241280597.","journal-title":"J Vitreoretin Dis"},{"key":"3589_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.108255","volume":"301","author":"LC Duke","year":"2025","unstructured":"Duke LC, Cone AS, Sun L, Dittmer DP, Meckes DG, Tomko RJ. Tetraspanin CD9 alters cellular trafficking and endocytosis of tetraspanin CD63, affecting CD63 packaging into small extracellular vesicles. J Biol Chem. 2025;301: 108255.","journal-title":"J Biol Chem"},{"issue":"11","key":"3589_CR200","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1034\/j.1600-0854.2003.00128.x","volume":"4","author":"RG Parton","year":"2003","unstructured":"Parton RG, Richards AA. Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic. 2003;4(11):724\u201338.","journal-title":"Traffic"},{"issue":"5","key":"3589_CR201","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1600-0854.2010.01041.x","volume":"11","author":"D Feng","year":"2010","unstructured":"Feng D, Zhao WL, Ye YY, Bai XC, Liu RQ, Chang LF, Zhou Q, Sui SF. Cellular internalization of exosomes occurs through phagocytosis. Traffic. 2010;11(5):675\u201387.","journal-title":"Traffic"},{"issue":"16","key":"3589_CR202","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.3390\/ijms21165840","volume":"21","author":"W Olejarz","year":"2020","unstructured":"Olejarz W, Kubiak-Tomaszewska G, Chrzanowska A, Lorenc T. Exosomes in angiogenesis and anti-angiogenic therapy in cancers. Int J Mol Sci. 2020;21(16):5840.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3589_CR203","doi-asserted-by":"publisher","first-page":"7644","DOI":"10.1021\/acsnano.4c00699","volume":"18","author":"H Zhang","year":"2024","unstructured":"Zhang H, Mao Y, Nie Z, Li Q, Wang M, Cai C, Hao W, Shen X, Gu N, Shen W, Song H. Iron oxide nanoparticles engineered macrophage-derived exosomes for targeted pathological angiogenesis therapy. ACS Nano. 2024;18(10):7644\u201355.","journal-title":"ACS Nano"},{"key":"3589_CR204","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/540416","volume":"2013","author":"D Petrovi\u010d","year":"2013","unstructured":"Petrovi\u010d D. Candidate genes for proliferative diabetic retinopathy. Biomed Res Int. 2013;2013: 540416.","journal-title":"Biomed Res Int"},{"issue":"4","key":"3589_CR205","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2147\/OPTH.S3361","volume":"2","author":"C Kaur","year":"2008","unstructured":"Kaur C, Foulds WS, Ling EA. Hypoxia-ischemia and retinal ganglion cell damage. Clin Ophthalmol. 2008;2(4):879\u201389.","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"3589_CR206","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41580-023-00631-w","volume":"24","author":"L P\u00e9rez-Guti\u00e9rrez","year":"2023","unstructured":"P\u00e9rez-Guti\u00e9rrez L, Ferrara N. Biology and therapeutic targeting of vascular endothelial growth factor A. Nat Rev Mol Cell Biol. 2023;24(11):816\u201334.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"Suppl 3","key":"3589_CR207","doi-asserted-by":"publisher","first-page":"S354","DOI":"10.4103\/IJO.IJO_3043_23","volume":"72","author":"D Wu","year":"2024","unstructured":"Wu D, Chan KE, Lim BXH, Lim DK, Wong WM, Chai C, Manotosh R, Lim CHL. Management of corneal neovascularization: current and emerging therapeutic approaches. Indian J Ophthalmol. 2024;72(Suppl 3):S354-s371.","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"3589_CR208","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/cells14050376","volume":"14","author":"H Seo","year":"2025","unstructured":"Seo H, Park SJ, Song M. Diabetic retinopathy (DR): mechanisms, current therapies, and emerging strategies. Cells. 2025;14(5):376.","journal-title":"Cells"},{"issue":"8","key":"3589_CR209","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.3390\/biomedicines10081996","volume":"10","author":"F Menna","year":"2022","unstructured":"Menna F, Meduri A, Lupo S, Vingolo EM. WAMD: from pathophysiology to therapeutic treatments. Biomedicines. 2022;10(8):1996.","journal-title":"Biomedicines."},{"issue":"1","key":"3589_CR210","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13041-024-01123-4","volume":"17","author":"Y Su","year":"2024","unstructured":"Su Y, Liu A, Chen H, Chen Q, Zhao B, Gao R, Zhang K, Peng T, Zhang Z, Ouyang C, Zhu D. Research progress of brain organoids in the field of diabetes. Mol Brain. 2024;17(1):53.","journal-title":"Mol Brain"},{"issue":"1","key":"3589_CR211","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/s12951-024-02943-1","volume":"22","author":"M Zhang","year":"2024","unstructured":"Zhang M, Lu X, Luo L, Dou J, Zhang J, Li G, Zhao L, Sun F. Targeting glutamine synthetase with AS1411-modified exosome-liposome hybrid nanoparticles for inhibition of choroidal neovascularization. J Nanobiotechnology. 2024;22(1):703.","journal-title":"J Nanobiotechnology"},{"issue":"11","key":"3589_CR212","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.7150\/thno.54755","volume":"11","author":"X Dong","year":"2021","unstructured":"Dong X, Lei Y, Yu Z, Wang T, Liu Y, Han G, Zhang X, Li Y, Song Y, Xu H, Du M, Yin H, Wang X, Yan H. Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis. Theranostics. 2021;11(11):5107\u201326.","journal-title":"Theranostics"},{"issue":"1","key":"3589_CR213","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12951-024-03079-y","volume":"23","author":"HY Zhang","year":"2025","unstructured":"Zhang HY, Zhang QY, Liu Q, Feng SG, Ma Y, Wang FS, Zhu Y, Yao J, Yan B. Exosome-loading miR-205: a two-pronged approach to ocular neovascularization therapy. J Nanobiotechnology. 2025;23(1):36.","journal-title":"J Nanobiotechnology"},{"issue":"13","key":"3589_CR214","doi-asserted-by":"publisher","first-page":"10917","DOI":"10.3390\/ijms241310917","volume":"24","author":"B Bhujel","year":"2023","unstructured":"Bhujel B, Oh SH, Kim CM, Yoon YJ, Kim YJ, Chung HS, Ye EA, Lee H, Kim JY. Mesenchymal stem cells and exosomes: a novel therapeutic approach for corneal diseases. Int J Mol Sci. 2023;24(13):10917.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3589_CR215","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3892\/etm.2021.11065","volume":"23","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Xu Y, Zhou K, Kao G, Xiao J. MicroRNA-126 and VEGF enhance the function of endothelial progenitor cells in acute myocardial infarction. Exp Ther Med. 2022;23(2):142.","journal-title":"Exp Ther Med"},{"issue":"1","key":"3589_CR216","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11033-025-10642-9","volume":"52","author":"S Ahmadi","year":"2025","unstructured":"Ahmadi S, Gohari-Lasaki S, Jahangiri N, Ejlalidiz M, Saberiyan M. The multifaceted roles of exosomes in corneal biology: elucidation of underlying mechanisms and therapeutic applications. Mol Biol Rep. 2025;52(1):527.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"3589_CR217","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s13287-024-04107-2","volume":"15","author":"M Saleem","year":"2024","unstructured":"Saleem M, Shahzad KA, Marryum M, Singh S, Zhou Q, Du S, Wang S, Shao C. Shaikh, II, Exosome-based therapies for inflammatory disorders: a review of recent advances. Stem Cell Res Ther. 2024;15(1):477.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3589_CR218","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13287-024-03868-0","volume":"15","author":"M Akhlaghpasand","year":"2024","unstructured":"Akhlaghpasand M, Tavanaei R, Hosseinpoor M, Yazdani KO, Soleimani A, Zoshk MY, Soleimani M, Chamanara M, Ghorbani M, Deylami M, Zali A, Heidari R, Oraee-Yazdani S. Safety and potential effects of intrathecal injection of allogeneic human umbilical cord mesenchymal stem cell-derived exosomes in complete subacute spinal cord injury: a first-in-human, single-arm, open-label, phase I clinical trial. Stem Cell Res Ther. 2024;15(1):264.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3589_CR219","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/cells10010042","volume":"10","author":"X Pu","year":"2020","unstructured":"Pu X, Ma S, Gao Y, Xu T, Chang P, Dong L. Mesenchymal stem cell-derived exosomes: biological function and their therapeutic potential in radiation damage. Cells. 2020;10(1):42.","journal-title":"Cells"},{"issue":"16","key":"3589_CR220","doi-asserted-by":"publisher","first-page":"12767","DOI":"10.3390\/ijms241612767","volume":"24","author":"I Gilyazova","year":"2023","unstructured":"Gilyazova I, Asadullina D, Kagirova E, Sikka R, Mustafin A, Ivanova E, Bakhtiyarova K, Gilyazova G, Gupta S, Khusnutdinova E, Gupta H, Pavlov V. MiRNA-146a-a key player in immunity and diseases. Int J Mol Sci. 2023;24(16):12767.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3589_CR221","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/pharmaceutics16111424","volume":"16","author":"BT Robbins","year":"2024","unstructured":"Robbins BT, Montreuil KA, Kundu N, Kumar P, Agrahari V. Corneal treatment repair, and regeneration: exosomes at rescue. Pharmaceutics. 2024;16(11):1424.","journal-title":"Pharmaceutics"},{"issue":"16","key":"3589_CR222","doi-asserted-by":"publisher","first-page":"8925","DOI":"10.3390\/ijms25168925","volume":"25","author":"S Lee","year":"2024","unstructured":"Lee S, Han J, Yang J, Lyu J, Park H, Bang J, Kim Y, Chang H, Park T. Exosomes from human iPSC-derived retinal organoids enhance corneal epithelial wound healing. Int J Mol Sci. 2024;25(16):8925.","journal-title":"Int J Mol Sci"},{"key":"3589_CR223","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108138","volume":"198","author":"TB McKay","year":"2020","unstructured":"McKay TB, Schl\u00f6tzer-Schrehardt U, Pal-Ghosh S, Stepp MA. Integrin: basement membrane adhesion by corneal epithelial and endothelial cells. Exp Eye Res. 2020;198: 108138.","journal-title":"Exp Eye Res"},{"key":"3589_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123205","volume":"319","author":"GS Liu","year":"2025","unstructured":"Liu GS, Chen HA, Chang CY, Chen YJ, Wu YY, Widhibrata A, Yang YH, Hsieh EH, Delila L, Lin IC, Burnouf T, Tseng CL. Platelet-derived extracellular vesicle drug delivery system loaded with kaempferol for treating corneal neovascularization. Biomaterials. 2025;319: 123205.","journal-title":"Biomaterials"},{"issue":"2","key":"3589_CR225","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409207","volume":"12","author":"J Yang","year":"2025","unstructured":"Yang J, Kang H, Liu Y, Lu S, Wu H, Zhang B, He Y, Zhou W. Harnessing tumor cell-derived exosomes for immune rejection management in corneal transplantation. Adv Sci (Weinh). 2025;12(2): e2409207.","journal-title":"Adv Sci (Weinh)."},{"issue":"14","key":"3589_CR226","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93751","volume":"2","author":"EJ Duh","year":"2017","unstructured":"Duh EJ, Sun JK, Stitt AW. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight. 2017;2(14): e93751.","journal-title":"JCI Insight"},{"issue":"6","key":"3589_CR227","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/ijms19061816","volume":"19","author":"W Wang","year":"2018","unstructured":"Wang W, Lo ACY. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci. 2018;19(6):1816.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3589_CR228","first-page":"11234","volume":"2014","author":"JR Evans","year":"2014","unstructured":"Evans JR, Michelessi M, Virgili G. Laser photocoagulation for proliferative diabetic retinopathy. Cochrane Database Syst Rev. 2014;2014(11):11234.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"3589_CR229","doi-asserted-by":"publisher","DOI":"10.1136\/bmjph-2024-001353","volume":"3","author":"X Pei","year":"2025","unstructured":"Pei X, Li Z. Narrative review of comprehensive management strategies for diabetic retinopathy: interdisciplinary approaches and future perspectives. BMJ Public Health. 2025;3(1): e001353.","journal-title":"BMJ Public Health"},{"issue":"21","key":"3589_CR230","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.3390\/cells11213362","volume":"11","author":"J Zhang","year":"2022","unstructured":"Zhang J, Zhang J, Zhang C, Zhang J, Gu L, Luo D, Qiu Q. Diabetic macular edema: current understanding, molecular mechanisms and therapeutic implications. Cells. 2022;11(21):3362.","journal-title":"Cells"},{"issue":"5","key":"3589_CR231","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4093\/dmj.2018.0182","volume":"42","author":"S Kusuhara","year":"2018","unstructured":"Kusuhara S, Fukushima Y, Ogura S, Inoue N, Uemura A. Pathophysiology of diabetic retinopathy: the old and the new. Diabetes Metab J. 2018;42(5):364\u201376.","journal-title":"Diabetes Metab J"},{"issue":"1","key":"3589_CR232","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-025-02249-0","volume":"10","author":"C Lee","year":"2025","unstructured":"Lee C, Kim MJ, Kumar A, Lee HW, Yang Y, Kim Y. Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives. Signal Transduct Target Ther. 2025;10(1):170.","journal-title":"Signal Transduct Target Ther"},{"key":"3589_CR233","doi-asserted-by":"publisher","first-page":"1583992","DOI":"10.3389\/fmolb.2025.1583992","volume":"12","author":"G Schwarz","year":"2025","unstructured":"Schwarz G, Ren X, Xie W, Guo H, Jiang Y, Zhang J. Engineered exosomes: a promising drug delivery platform with therapeutic potential. Front Mol Biosci. 2025;12:1583992.","journal-title":"Front Mol Biosci"},{"issue":"5","key":"3589_CR234","doi-asserted-by":"publisher","first-page":"976","DOI":"10.4103\/1673-5374.355743","volume":"18","author":"L Tang","year":"2023","unstructured":"Tang L, Xu GT, Zhang JF. Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy. Neural Regen Res. 2023;18(5):976\u201382.","journal-title":"Neural Regen Res"},{"issue":"3","key":"3589_CR235","first-page":"1225","volume":"16","author":"H Yu","year":"2024","unstructured":"Yu H, Wu J, Pan G. Targeting the ophthalmic diseases using extracellular vesicles \u2018exosomes\u2019: current insights on their clinical approval and present trials. Aging Dis. 2024;16(3):1225\u201341.","journal-title":"Aging Dis"},{"issue":"9","key":"3589_CR236","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41419-020-02955-3","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, Tang Z, Gu P. Stem\/progenitor cell-based transplantation for retinal degeneration: a review of clinical trials. Cell Death Dis. 2020;11(9):793.","journal-title":"Cell Death Dis"},{"issue":"7","key":"3589_CR237","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268451","volume":"17","author":"Y Li","year":"2022","unstructured":"Li Y, Gappy S, Liu X, Sassalos T, Zhou T, Hsu A, Zhang A, Edwards PA, Gao H, Qiao X. Metformin suppresses pro-inflammatory cytokines in vitreous of diabetes patients and human retinal vascular endothelium. PLoS ONE. 2022;17(7): e0268451.","journal-title":"PLoS ONE"},{"issue":"1","key":"3589_CR238","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1038\/s41467-024-48852-7","volume":"15","author":"Y El Bakkouri","year":"2024","unstructured":"El Bakkouri Y, Chidiac R, Delisle C, Corriveau J, Cagnone G, Gaonac\u2019h-Lovejoy V, Chin A, L\u00e9cuyer \u00c9, Angers S, Joyal JS, Topisirovic I, Hulea L, Dubrac A, Gratton JP. ZO-1 interacts with YB-1 in endothelial cells to regulate stress granule formation during angiogenesis. Nat Commun. 2024;15(1):4405.","journal-title":"Nat Commun"},{"issue":"6","key":"3589_CR239","doi-asserted-by":"publisher","first-page":"sxaf023","DOI":"10.1093\/stmcls\/sxaf023","volume":"43","author":"J Tong","year":"2025","unstructured":"Tong J, Chen Y, Ling X, Huang Z, Yao G, Xie Z. MSC-derived exosomal miR-125b-5p suppressed retinal microvascular endothelial cell ferroptosis in diabetic retinopathy. Stem Cells. 2025;43(6):sxaf023.","journal-title":"Stem Cells"},{"issue":"4","key":"3589_CR240","doi-asserted-by":"publisher","first-page":"300060521100297","DOI":"10.1177\/03000605211002975","volume":"49","author":"L Jiang","year":"2021","unstructured":"Jiang L, Cao H, Deng T, Yang M, Meng T, Yang H, Luo X. Serum exosomal miR-377-3p inhibits retinal pigment epithelium proliferation and offers a biomarker for diabetic macular edema. J Int Med Res. 2021;49(4):3000605211002975.","journal-title":"J Int Med Res"},{"issue":"15","key":"3589_CR241","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.21037\/atm-20-4417","volume":"9","author":"SH Chung","year":"2021","unstructured":"Chung SH, Frick SL, Yiu G. Targeting vascular endothelial growth factor using retinal gene therapy. Ann Transl Med. 2021;9(15):1277.","journal-title":"Ann Transl Med"},{"key":"3589_CR242","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.reth.2024.08.001","volume":"26","author":"HJ Liao","year":"2024","unstructured":"Liao HJ, Yang YP, Liu YH, Tseng HC, Huo TI, Chiou SH, Chang CH. Harnessing the potential of mesenchymal stem cells-derived exosomes in degenerative diseases. Regen Ther. 2024;26:599\u2013610.","journal-title":"Regen Ther"},{"issue":"3","key":"3589_CR243","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1172\/JCI31030","volume":"117","author":"M Friedlander","year":"2007","unstructured":"Friedlander M. Fibrosis and diseases of the eye. J Clin Invest. 2007;117(3):576\u201386.","journal-title":"J Clin Invest"},{"issue":"1","key":"3589_CR244","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s43556-025-00280-9","volume":"6","author":"S Huang","year":"2025","unstructured":"Huang S, Yan F, Qiu Y, Liu T, Zhang W, Yang Y, Zhong R, Yang Y, Peng X. Exosomes in inflammation and cancer: from bench to bedside applications. Mol Biomed. 2025;6(1):41.","journal-title":"Mol Biomed"},{"issue":"4","key":"3589_CR245","doi-asserted-by":"publisher","first-page":"762","DOI":"10.2337\/db21-0551","volume":"71","author":"Z Hu","year":"2022","unstructured":"Hu Z, Mao X, Chen M, Wu X, Zhu T, Liu Y, Zhang Z, Fan W, Xie P, Yuan S, Liu Q. Single-cell transcriptomics reveals novel role of microglia in fibrovascular membrane of proliferative diabetic retinopathy. Diabetes. 2022;71(4):762\u201373.","journal-title":"Diabetes"},{"issue":"13","key":"3589_CR246","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.3390\/ijms23137005","volume":"23","author":"S Liu","year":"2022","unstructured":"Liu S, Ju Y, Gu P. Experiment-based interventions to diabetic retinopathy: present and advances. Int J Mol Sci. 2022;23(13):7005.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3589_CR247","doi-asserted-by":"publisher","first-page":"502","DOI":"10.20517\/evcna.2023.32","volume":"4","author":"Q Chen","year":"2023","unstructured":"Chen Q, Chen J, Liu YN, Qi SH, Huang LY. Exosome-based drug delivery systems for the treatment of diabetes and its complications: current opinion. Extracell Vesicles Circ Nucl Acids. 2023;4(3):502\u201317.","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"issue":"2","key":"3589_CR248","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/cvr\/cvq105","volume":"87","author":"DO Bates","year":"2010","unstructured":"Bates DO. Vascular endothelial growth factors and vascular permeability. Cardiovasc Res. 2010;87(2):262\u201371.","journal-title":"Cardiovasc Res"},{"issue":"12","key":"3589_CR249","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","volume":"119","author":"JS Heier","year":"2012","unstructured":"Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Groetzbach G, Sommerauer B, Sandbrink R, Simader C, Schmidt-Erfurth U. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012;119(12):2537\u201348.","journal-title":"Ophthalmology"},{"issue":"5","key":"3589_CR250","doi-asserted-by":"publisher","first-page":"e706","DOI":"10.1111\/aos.14046","volume":"97","author":"K Spooner","year":"2019","unstructured":"Spooner K, Hong T, Nair R, Chow NCC, Broadhead GK, Wijeyakumar W, Chang AA. Long-term outcomes of switching to aflibercept for treatment-resistant neovascular age-related macular degeneration. Acta Ophthalmol. 2019;97(5):e706\u201312.","journal-title":"Acta Ophthalmol"},{"key":"3589_CR251","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120264","volume":"257","author":"T Wang","year":"2020","unstructured":"Wang T, Jian Z, Baskys A, Yang J, Li J, Guo H, Hei Y, Xian P, He Z, Li Z, Li N, Long Q. MSC-derived exosomes protect against oxidative stress-induced skin injury via adaptive regulation of the NRF2 defense system. Biomaterials. 2020;257: 120264.","journal-title":"Biomaterials"},{"key":"3589_CR252","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114107","volume":"182","author":"Z Meng","year":"2022","unstructured":"Meng Z, Zhang Y, Zhou X, Ji J, Liu Z. Nanovaccines with cell-derived components for cancer immunotherapy. Adv Drug Deliv Rev. 2022;182: 114107.","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"3589_CR253","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/jcm8081105","volume":"8","author":"CW Hsu","year":"2019","unstructured":"Hsu CW, Huang TL, Tsai MC. Decreased level of blood microRNA-133b in men with opioid use disorder on methadone maintenance therapy. J Clin Med. 2019;8(8):1105.","journal-title":"J Clin Med"},{"issue":"1","key":"3589_CR254","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13287-021-02264-2","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Ye L, Xu H, Zhou Q, Tan B, Yi Q, Yan L, Xie M, Zhang Y, Tian J, Zhu J. NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes. Stem Cell Res Ther. 2021;12(1):208.","journal-title":"Stem Cell Res Ther"},{"key":"3589_CR255","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100602","volume":"19","author":"X Gui","year":"2023","unstructured":"Gui X, Zhang H, Zhang R, Li Q, Zhu W, Nie Z, Zhao J, Cui X, Hao W, Wen X, Shen W, Song H. Exosomes incorporated with black phosphorus quantum dots attenuate retinal angiogenesis via disrupting glucose metabolism. Mater Today Bio. 2023;19: 100602.","journal-title":"Mater Today Bio"},{"issue":"8","key":"3589_CR256","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1111\/jcmm.12834","volume":"20","author":"S Atienzar-Aroca","year":"2016","unstructured":"Atienzar-Aroca S, Flores-Bellver M, Serrano-Heras G, Martinez-Gil N, Barcia JM, Aparicio S, Perez-Cremades D, Garcia-Verdugo JM, Diaz-Llopis M, Romero FJ, Sancho-Pelluz J. Oxidative stress in retinal pigment epithelium cells increases exosome secretion and promotes angiogenesis in endothelial cells. J Cell Mol Med. 2016;20(8):1457\u201366.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"3589_CR257","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1161\/CIRCRESAHA.117.309681","volume":"120","author":"D Todorova","year":"2017","unstructured":"Todorova D, Simoncini S, Lacroix R, Sabatier F, Dignat-George F. Extracellular vesicles in angiogenesis. Circ Res. 2017;120(10):1658\u201373.","journal-title":"Circ Res"},{"issue":"14","key":"3589_CR258","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419\u201331.","journal-title":"N Engl J Med"},{"key":"3589_CR259","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2022.02.027","volume":"143","author":"B Basu","year":"2022","unstructured":"Basu B, Gowtham NH, Xiao Y, Kalidindi SR, Leong KW. Biomaterialomics: Data science-driven pathways to develop fourth-generation biomaterials. Acta Biomater. 2022;143:1\u201325.","journal-title":"Acta Biomater"},{"key":"3589_CR260","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.preteyeres.2012.10.001","volume":"33","author":"Y Chen","year":"2013","unstructured":"Chen Y, Thompson DC, Koppaka V, Jester JV, Vasiliou V. Ocular aldehyde dehydrogenases: protection against ultraviolet damage and maintenance of transparency for vision. Prog Retin Eye Res. 2013;33:28\u201339.","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"3589_CR261","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/iovs.61.3.28","volume":"61","author":"JA Germann","year":"2020","unstructured":"Germann JA, Mart\u00ednez-Enr\u00edquez E, Mart\u00ednez-Garc\u00eda MC, Kochevar IE, Marcos S. Corneal collagen ordering after in vivo rose bengal and riboflavin cross-linking. Invest Ophthalmol Vis Sci. 2020;61(3):28.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3589_CR262","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13287-021-02194-z","volume":"12","author":"W Yan","year":"2021","unstructured":"Yan W, Diao S, Fan Z. The role and mechanism of mitochondrial functions and energy metabolism in the function regulation of the mesenchymal stem cells. Stem Cell Res Ther. 2021;12(1):140.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3589_CR263","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/s41467-022-28925-1","volume":"13","author":"SA Yeh","year":"2022","unstructured":"Yeh SA, Hou J, Wu JW, Yu S, Zhang Y, Belfield KD, Camargo FD, Lin CP. Publisher correction: quantification of bone marrow interstitial pH and calcium concentration by intravital ratiometric imaging. Nat Commun. 2022;13(1):1563.","journal-title":"Nat Commun"},{"issue":"3","key":"3589_CR264","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.ymthe.2022.01.025","volume":"30","author":"P Chaturvedi","year":"2022","unstructured":"Chaturvedi P, George V, Shrestha N, Wang M, Dee MJ, Zhu X, Liu B, Egan J, D\u2019Eramo F, Spanoudis C, Gallo V, Echeverri C, You L, Kong L, Fang B, Jeng EK, Rhode PR, Wong HC. Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells. Mol Ther. 2022;30(3):1171\u201387.","journal-title":"Mol Ther"},{"key":"3589_CR265","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.omtn.2022.03.020","volume":"28","author":"G Bi","year":"2022","unstructured":"Bi G, Liang J, Zhao M, Zhang H, Jin X, Lu T, Zheng Y, Bian Y, Chen Z, Huang Y, Besskaya V, Zhan C, Wang Q, Tan L. miR-6077 promotes cisplatin\/pemetrexed resistance in lung adenocarcinoma via CDKN1A\/cell cycle arrest and KEAP1\/ferroptosis pathways. Mol Ther Nucleic Acids. 2022;28:366\u201386.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7659","key":"3589_CR266","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, Lee JJ, Kalluri R. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498\u2013503.","journal-title":"Nature"},{"issue":"1","key":"3589_CR267","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/mt.2012.180","volume":"21","author":"S Ohno","year":"2013","unstructured":"Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T, Gotoh N, Kuroda M. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther. 2013;21(1):185\u201391.","journal-title":"Mol Ther"},{"key":"3589_CR268","doi-asserted-by":"publisher","first-page":"34025","DOI":"10.1038\/srep34025","volume":"6","author":"T Wu","year":"2016","unstructured":"Wu T, Dufford AJ, Mackie MA, Egan LJ, Fan J. The capacity of cognitive control estimated from a perceptual decision making task. Sci Rep. 2016;6:34025.","journal-title":"Sci Rep"},{"issue":"6","key":"3589_CR269","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12087","volume":"10","author":"JA Mart\u00ednez-Greene","year":"2021","unstructured":"Mart\u00ednez-Greene JA, Hern\u00e1ndez-Ortega K, Quiroz-Baez R, Resendis-Antonio O, Pichardo-Casas I, Sinclair DA, Budnik B, Hidalgo-Miranda A, Uribe-Querol E, Ramos-God\u00ednez MDP, Mart\u00ednez-Mart\u00ednez E. Quantitative proteomic analysis of extracellular vesicle subgroups isolated by an optimized method combining polymer-based precipitation and size exclusion chromatography. J Extracell Vesicles. 2021;10(6): e12087.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"3589_CR270","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s13287-020-02018-6","volume":"11","author":"F Rossi","year":"2020","unstructured":"Rossi F, Noren H, Jove R, Beljanski V, Grinnemo KH. Differences and similarities between cancer and somatic stem cells: therapeutic implications. Stem Cell Res Ther. 2020;11(1):489.","journal-title":"Stem Cell Res Ther"},{"key":"3589_CR271","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.949724","volume":"10","author":"Z Gu","year":"2022","unstructured":"Gu Z, Yin Z, Song P, Wu Y, He Y, Zhu M, Wu Z, Zhao S, Huang H, Wang H, Tong C, Qi Z. Safety and biodistribution of exosomes derived from human induced pluripotent stem cells. Front Bioeng Biotechnol. 2022;10: 949724.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"3589_CR272","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12964-022-00959-4","volume":"20","author":"J Rezaie","year":"2022","unstructured":"Rezaie J, Feghhi M, Etemadi T. A review on exosomes application in clinical trials: perspective, questions, and challenges. Cell Commun Signal. 2022;20(1):145.","journal-title":"Cell Commun Signal"},{"key":"3589_CR273","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.3390\/ijms20194684","volume":"20","author":"N Ludwig","year":"2019","unstructured":"Ludwig N, Whiteside T, Reichert T. Challenges in exosome isolation and analysis in health and disease. Int J Mol Sci. 2019;20:4684.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3589_CR274","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.3390\/biomedicines11082099","volume":"11","author":"P Sousa","year":"2023","unstructured":"Sousa P, Lopes B, Sousa AC, Moreira A, Coelho A, Alvites R, Sousa \u00c2, Geuna S, Maur\u00edcio AC. Advancements and insights in exosome-based therapies for wound healing: a comprehensive systematic review (2018\u2013June 2023). Biomedicines. 2023;11(8):2099.","journal-title":"Biomedicines"},{"issue":"4","key":"3589_CR275","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3390\/molecules26041135","volume":"26","author":"T Barjesteh","year":"2021","unstructured":"Barjesteh T, Mansur S, Bao Y. Inorganic nanoparticle-loaded exosomes for biomedical applications. Molecules. 2021;26(4):1135.","journal-title":"Molecules"},{"issue":"8","key":"3589_CR276","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13904","volume":"17","author":"CK Wang","year":"2024","unstructured":"Wang CK, Tsai TH, Lee CH. Regulation of exosomes as biologic medicines: regulatory challenges faced in exosome development and manufacturing processes. Clin Transl Sci. 2024;17(8): e13904.","journal-title":"Clin Transl Sci"},{"issue":"11","key":"3589_CR277","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.stemcr.2024.09.008","volume":"19","author":"M Fujita","year":"2024","unstructured":"Fujita M, Hatta T, Ikka T, Onishi T. The urgent need for clear and concise regulations on exosome-based interventions. Stem Cell Reports. 2024;19(11):1517\u20139.","journal-title":"Stem Cell Reports"},{"issue":"6","key":"3589_CR278","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1248\/bpb.b18-00133","volume":"41","author":"T Yamashita","year":"2018","unstructured":"Yamashita T, Takahashi Y, Takakura Y. Possibility of exosome-based therapeutics and challenges in production of exosomes eligible for therapeutic application. Biol Pharm Bull. 2018;41(6):835\u201342.","journal-title":"Biol Pharm Bull"},{"key":"3589_CR279","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.2147\/IJN.S444582","volume":"18","author":"J Tian","year":"2023","unstructured":"Tian J. Engineered exosome for drug delivery: recent development and clinical applications. Int J Nanomed. 2023;18:7923\u201340.","journal-title":"Int J Nanomed"},{"key":"3589_CR280","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3390\/pharmaceutics15020598","volume":"15","author":"Y Lu","year":"2023","unstructured":"Lu Y, Huang W, Li M, Zheng A. Exosome-based carrier for RNA delivery: progress and challenges. Pharmaceutics. 2023;15:598.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3589_CR281","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s13287-024-04005-7","volume":"15","author":"S Ahmadian","year":"2024","unstructured":"Ahmadian S, Jafari N, Tamadon A, Ghaffarzadeh A, Rahbarghazi R, Mahdipour M. Different storage and freezing protocols for extracellular vesicles: a systematic review. Stem Cell Res Ther. 2024;15(1):453.","journal-title":"Stem Cell Res Ther"},{"key":"3589_CR282","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jconrel.2024.02.015","volume":"368","author":"Y Wang","year":"2024","unstructured":"Wang Y, Huo Y, Zhao C, Liu H, Shao Y, Zhu C, An L, Chen X, Chen Z. Engineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy. J Control Release. 2024;368:170\u201383.","journal-title":"J Control Release"},{"issue":"4","key":"3589_CR283","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/pharmaceutics15041094","volume":"15","author":"KY Wu","year":"2023","unstructured":"Wu KY, Joly-Chevrier M, Akbar D, Tran SD. Overcoming treatment challenges in posterior segment diseases with biodegradable nano-based drug delivery systems. Pharmaceutics. 2023;15(4):1094.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3589_CR284","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41392-023-01704-0","volume":"9","author":"F Tan","year":"2024","unstructured":"Tan F, Li X, Wang Z, Li J, Shahzad K, Zheng J. Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther. 2024;9(1):17.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3589_CR285","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70036","volume":"14","author":"R Crescitelli","year":"2025","unstructured":"Crescitelli R, Falcon-Perez J, Hendrix A, Lenassi M, Minh LTN, Ochiya T, Noren Hooten N, Sandau U, Thery C, Nieuwland R. Reproducibility of extracellular vesicle research. J Extracell Vesicles. 2025;14(1): e70036.","journal-title":"J Extracell Vesicles."},{"issue":"15","key":"3589_CR286","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202200060","volume":"18","author":"G Kwak","year":"2022","unstructured":"Kwak G, Cheng J, Kim H, Song S, Lee SJ, Yang Y, Jeong JH, Lee JE, Messersmith PB, Kim SH. Sustained exosome-guided macrophage polarization using hydrolytically degradable PEG Hydrogels for cutaneous wound healing: identification of key proteins and MiRNAs, and sustained release formulation. Small. 2022;18(15): e2200060.","journal-title":"Small"},{"key":"3589_CR287","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.biochi.2023.05.010","volume":"213","author":"F Mehryab","year":"2023","unstructured":"Mehryab F, Taghizadeh F, Goshtasbi N, Merati F, Rabbani S, Haeri A. Exosomes as cutting-edge therapeutics in various biomedical applications: an update on engineering, delivery, and preclinical studies. Biochimie. 2023;213:139\u201367.","journal-title":"Biochimie"},{"issue":"9","key":"3589_CR288","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1517\/17425255.2010.486401","volume":"6","author":"M Tomi","year":"2010","unstructured":"Tomi M, Hosoya K. The role of blood-ocular barrier transporters in retinal drug disposition: an overview. Expert Opin Drug Metab Toxicol. 2010;6(9):1111\u201324.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3589_CR289","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2023.07.028","volume":"361","author":"E Ramsay","year":"2023","unstructured":"Ramsay E, Lajunen T, Bhattacharya M, Reinisalo M, Rilla K, Kidron H, Terasaki T, Urtti A. Selective drug delivery to the retinal cells: biological barriers and avenues. J Control Release. 2023;361:1\u201319.","journal-title":"J Control Release"},{"issue":"1","key":"3589_CR290","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13287-025-04160-5","volume":"16","author":"J Quan","year":"2025","unstructured":"Quan J, Liu Q, Li P, Yang Z, Zhang Y, Zhao F, Zhu G. Mesenchymal stem cell exosome therapy: current research status in the treatment of neurodegenerative diseases and the possibility of reversing normal brain aging. Stem Cell Res Ther. 2025;16(1):76.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"3589_CR291","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00128-025-04014-z","volume":"114","author":"ME Ozgur","year":"2025","unstructured":"Ozgur ME, Maras Z, Aydemir S, Acari IK, Erdogan S, Charles S, Koytepe S. Zinc sulfur nanoparticles cause both the negatory vitality and bioaccumulation on gammarus pulex. Bull Environ Contam Toxicol. 2025;114(3):36.","journal-title":"Bull Environ Contam Toxicol"},{"issue":"1","key":"3589_CR292","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70030","volume":"14","author":"G Adamo","year":"2025","unstructured":"Adamo G, Picciotto S, Gargano P, Paterna A, Raccosta S, Rao E, Romancino DP, Ghersi G, Manno M, Salamone M, Bongiovanni A. DetectEV: a functional enzymatic assay to assess integrity and bioactivity of extracellular vesicles. J Extracell Vesicles. 2025;14(1): e70030.","journal-title":"J Extracell Vesicles"},{"key":"3589_CR293","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/stcltm\/szae027","volume":"13","author":"M Kim","year":"2024","unstructured":"Kim M, Choi H, Jang D-J, Kim H-J, Sub Y, Gee H, Choi C. Exploring the clinical transition of engineered exosomes designed for intracellular delivery of therapeutic proteins. Stem Cells Transl Med. 2024;13:637\u201347.","journal-title":"Stem Cells Transl Med"},{"key":"3589_CR294","doi-asserted-by":"publisher","first-page":"961127","DOI":"10.3389\/fphar.2022.961127","volume":"13","author":"Y Yin","year":"2022","unstructured":"Yin Y, Han X, Li C, Sun T, Li K, Liu X, Liu M. The status of industrialization and development of exosomes as a drug delivery system: a review. Front Pharmacol. 2022;13:961127.","journal-title":"Front Pharmacol"},{"issue":"7","key":"3589_CR295","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.3390\/ijms25073645","volume":"25","author":"X Wang","year":"2024","unstructured":"Wang X. Enhanced therapeutic potential of hybrid exosomes loaded with paclitaxel for cancer therapy. IJMS. 2024;25(7):3645.","journal-title":"IJMS"},{"key":"3589_CR296","doi-asserted-by":"publisher","DOI":"10.1101\/2022.04.06.487362","author":"JW Simpkins","year":"2022","unstructured":"Simpkins JW, Corbin D, Sarkar SN. Mouse brain-wide transgene expression by systemic injection of genetically engineered exosomes: CAP-exosomes. Biorxiv. 2022. https:\/\/doi.org\/10.1101\/2022.04.06.487362.","journal-title":"Biorxiv"},{"key":"3589_CR297","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202403935","author":"M Xie","year":"2024","unstructured":"Xie M, Wu Y, Zhang Y, Lu R, Zhai Z, Huang Y, Wang F, Xin C, Rong G, Zhao C, Jiang K, Zhou X, Zhou X, Zhu X, Hong J, Zhang C. Membrane fusion-mediated loading of therapeutic siRNA into exosome for tissue-specific application. Adv Mater. 2024. https:\/\/doi.org\/10.1002\/adma.202403935.","journal-title":"Adv Mater"},{"issue":"30","key":"3589_CR298","doi-asserted-by":"publisher","first-page":"2100722","DOI":"10.1002\/adfm.202100722","volume":"31","author":"A Zinger","year":"2021","unstructured":"Zinger A, Soriano S, Baudo G, De Rosa E, Taraballi F, Villapol S. Biomimetic nanoparticles as a theranostic tool for traumatic brain injury. Adv Funct Mater. 2021;31(30):2100722.","journal-title":"Adv Funct Mater"},{"key":"3589_CR299","doi-asserted-by":"publisher","first-page":"6253","DOI":"10.2147\/IJN.S459710","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, Deng T, Liu X, Fang X, Mo Y, Xie N, Nie G, Zhang B, Fan X. Smart nanoplatforms responding to the tumor microenvironment for precise drug delivery in cancer therapy. Int J Nanomedicine. 2024;19:6253\u201377.","journal-title":"Int J Nanomedicine"},{"issue":"11","key":"3589_CR300","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1080\/17425247.2021.1968826","volume":"18","author":"AM Khanani","year":"2021","unstructured":"Khanani AM, Aziz AA, Weng CY, Lin WV, Vannavong J, Chhablani J, Danzig CJ, Kaiser PK. Port delivery system: a novel drug delivery platform to treat retinal diseases. Expert Opin Drug Deliv. 2021;18(11):1571\u20136.","journal-title":"Expert Opin Drug Deliv"},{"key":"3589_CR301","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.3c00144","author":"J Liu","year":"2023","unstructured":"Liu J, Sun J, Song Y, Wang M, Zhao P, Wang W, Yang M, Wang Y, Song Y, Sun B. Prussian blue nanozyme treatment of ischemic brain injury via reducing oxidative stress inhibits inflammation, suppresses apoptosis, and promotes neurological recovery. ACS Chem Neurosci. 2023. https:\/\/doi.org\/10.1021\/acschemneuro.3c00144.","journal-title":"ACS Chem Neurosci"},{"issue":"12","key":"3589_CR302","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206934","volume":"10","author":"Y Ling","year":"2023","unstructured":"Ling Y, Nie D, Huang Y, Deng M, Liu Q, Shi J, Ouyang S, Yang Y, Deng S, Lu Z, Yang J, Wang Y, Huang R, Shi W. Antioxidant cascade nanoenzyme antagonize inflammatory pain by modulating MAPK\/p-65 signaling pathway. Adv Sci (Weinh). 2023;10(12): e2206934.","journal-title":"Adv Sci (Weinh)."},{"issue":"16","key":"3589_CR303","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100876","volume":"8","author":"X Cheng","year":"2021","unstructured":"Cheng X, Gao J, Ding Y, Lu Y, Wei Q, Cui D, Fan J, Li X, Zhu E, Lu Y, Wu Q, Li L, Huang W. Multi-functional liposome: a powerful theranostic nano-platform enhancing photodynamic therapy. Adv Sci (Weinh). 2021;8(16): e2100876.","journal-title":"Adv Sci (Weinh)."},{"key":"3589_CR304","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2024.110022","volume":"756","author":"P Tiwari","year":"2024","unstructured":"Tiwari P, Yadav K, Shukla RP, Bakshi AK, Panwar D, Das S, Mishra PR. Extracellular vesicles-powered immunotherapy: unleashing the potential for safer and more effective cancer treatment. Arch Biochem Biophys. 2024;756: 110022.","journal-title":"Arch Biochem Biophys"},{"issue":"9","key":"3589_CR305","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1039\/C6TB03233H","volume":"5","author":"K Deng","year":"2017","unstructured":"Deng K, Chen Y, Li C, Deng X, Hou Z, Cheng Z, Han Y, Xing B, Lin J. 808 nm light responsive nanotheranostic agents based on near-infrared dye functionalized manganese ferrite for magnetic-targeted and imaging-guided photodynamic\/photothermal therapy. J Mater Chem B. 2017;5(9):1803\u201314.","journal-title":"J Mater Chem B"},{"issue":"5","key":"3589_CR306","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1021\/acscentsci.9b01299","volume":"6","author":"ZH Houston","year":"2020","unstructured":"Houston ZH, Bunt J, Chen KS, Puttick S, Howard CB, Fletcher NL, Fuchs AV, Cui J, Ju Y, Cowin G, Song X, Boyd AW, Mahler SM, Richards LJ, Caruso F, Thurecht KJ. Understanding the uptake of nanomedicines at different stages of brain cancer using a modular nanocarrier platform and precision bispecific antibodies. ACS Cent Sci. 2020;6(5):727\u201338.","journal-title":"ACS Cent Sci"},{"key":"3589_CR307","doi-asserted-by":"publisher","first-page":"1070479","DOI":"10.3389\/fonc.2022.1070479","volume":"12","author":"T Nonaka","year":"2022","unstructured":"Nonaka T. Application of engineered extracellular vesicles to overcome drug resistance in cancer. Front Oncol. 2022;12:1070479.","journal-title":"Front Oncol"},{"key":"3589_CR308","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115535","volume":"257","author":"D Jiang","year":"2023","unstructured":"Jiang D, Xu T, Zhong L, Liang Q, Hu Y, Xiao W, Shi J. Research progress of VEGFR small molecule inhibitors in ocular neovascular diseases. Eur J Med Chem. 2023;257: 115535.","journal-title":"Eur J Med Chem"},{"issue":"11","key":"3589_CR309","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3928\/23258160-20231016-01","volume":"54","author":"CY Weng","year":"2023","unstructured":"Weng CY, Singh RP, Gillies MC, Regillo CD. Optimizing visual outcomes in patients with neovascular age-related macular degeneration: the potential value of sustained anti-VEGF therapy. Ophthalmic Surg Lasers Imaging Retina. 2023;54(11):654\u20139.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"3","key":"3589_CR310","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/biom14030252","volume":"14","author":"Y Fu","year":"2024","unstructured":"Fu Y, Zhang Z, Webster KA, Paulus YM. Treatment strategies for anti-VEGF resistance in neovascular age-related macular degeneration by targeting arteriolar choroidal neovascularization. Biomolecules. 2024;14(3):252.","journal-title":"Biomolecules"},{"key":"3589_CR311","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.06.029","author":"E Durmaz","year":"2024","unstructured":"Durmaz E, Dribika L, Kutnyanszky M, Mead B. Utilizing extracellular vesicles as a drug delivery system in glaucoma and RGC degeneration. J Control Release. 2024. https:\/\/doi.org\/10.1016\/j.jconrel.2024.06.029.","journal-title":"J Control Release"},{"issue":"2","key":"3589_CR312","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3390\/pharmaceutics15020663","volume":"15","author":"M Casajuana Ester","year":"2023","unstructured":"Casajuana Ester M, Day RM. Production and utility of extracellular vesicles with 3D culture methods. Pharmaceutics. 2023;15(2):663.","journal-title":"Pharmaceutics"},{"issue":"4","key":"3589_CR313","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"3589_CR314","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13312","volume":"55","author":"A Bordin","year":"2022","unstructured":"Bordin A, Chiriv\u00ec M, Pagano F, Milan M, Iuliano M, Scaccia E, Fortunato O, Mangino G, Dhori X, De Marinis E, D\u2019Amico A, Miglietta S, Picchio V, Rizzi R, Romeo G, Pulcinelli F, Chimenti I, Frati G, De Falco E. Human platelet lysate-derived extracellular vesicles enhance angiogenesis through miR-126. Cell Prolif. 2022;55(11): e13312.","journal-title":"Cell Prolif"},{"issue":"4","key":"3589_CR315","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1007\/s12035-022-03197-4","volume":"60","author":"V Ebrahimi","year":"2023","unstructured":"Ebrahimi V, Rastegar-Moghaddam SH, Mohammadipour A. Therapeutic potentials of microRNA-126 in cerebral ischemia. Mol Neurobiol. 2023;60(4):2062\u20139.","journal-title":"Mol Neurobiol"},{"issue":"6","key":"3589_CR316","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41419-021-03803-8","volume":"12","author":"Q He","year":"2021","unstructured":"He Q, Ye A, Ye W, Liao X, Qin G, Xu Y, Yin Y, Luo H, Yi M, Xian L, Zhang S, Qin X, Zhu W, Li Y. Cancer-secreted exosomal miR-21-5p induces angiogenesis and vascular permeability by targeting KRIT1. Cell Death Dis. 2021;12(6):576.","journal-title":"Cell Death Dis"},{"issue":"4","key":"3589_CR317","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.ymthe.2020.12.033","volume":"29","author":"MJ Cox","year":"2021","unstructured":"Cox MJ, Lucien F, Sakemura R, Boysen JC, Kim Y, Horvei P, Manriquez Roman C, Hansen MJ, Tapper EE, Siegler EL, Forsman C, Crotts SB, Schick KJ, Hefazi M, Ruff MW, Can I, Adada M, Bezerra E, Kankeu Fonkoua LA, Nevala WK, Braggio E, Ding W, Parikh SA, Kay NE, Kenderian SS. Leukemic extracellular vesicles induce chimeric antigen receptor T\u00a0cell dysfunction in chronic lymphocytic leukemia. Mol Ther. 2021;29(4):1529\u201340.","journal-title":"Mol Ther"},{"key":"3589_CR318","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.107846","volume":"189","author":"Z Yi","year":"2019","unstructured":"Yi Z, Xiao X, Li S, Sun W, Zhang Q. Pathogenicity discrimination and genetic test reference for CRX variants based on genotype-phenotype analysis. Exp Eye Res. 2019;189: 107846.","journal-title":"Exp Eye Res"},{"key":"3589_CR319","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2024.2374869","author":"LW Rowe","year":"2024","unstructured":"Rowe LW, Ciulla TA. Long acting delivery and therapies for neovascular age-related macular degeneration. Expert Opin Biol Ther. 2024. https:\/\/doi.org\/10.1080\/14712598.2024.2374869.","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"3589_CR320","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12886-020-01554-2","volume":"20","author":"RP Finger","year":"2020","unstructured":"Finger RP, Daien V, Eldem BM, Talks JS, Korobelnik JF, Mitchell P, Sakamoto T, Wong TY, Pantiri K, Carrasco J. Anti-vascular endothelial growth factor in neovascular age-related macular degeneration\u2014a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems. BMC Ophthalmol. 2020;20(1):294.","journal-title":"BMC Ophthalmol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03589-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03589-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03589-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:23:35Z","timestamp":1757258615000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03589-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":320,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3589"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03589-3","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics and Consent to Participate declarations: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have consented to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"526"}}